Case number 1:18-cv-12029
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 8, 2023 | 706 | Notice of Appeal* (1) |
| Nov 7, 2023 | 704 | Notice of Appeal* (1) |
| Oct 24, 2023 | 701 | Notice of Appeal* (1) |
| Sep 28, 2023 | 697 | Judge Allison D. Burroughs: ORDER entered. JUDGMENT. (McManus, Caetlin) (Entered: 09/28/2023) (1) |
| Sep 28, 2023 | 698 | REPORT ON THE TERMINATION OF AN ACTION REGARDING PATENT OR TRADEMARK. (McManus, Caetlin) (Entered: 09/28/2023) (2) |
| Sep 26, 2023 | 695 | Judge Allison D. Burroughs: MEMORANDUM AND ORDER entered. Lilly's motion for judgment as a matter of law, [ECF No. 649 ], is GRANTED insofar as the Patents-in-Suit are invalid on the basis of inadequate written description and lack of enablement, and DENIED as to the issue of future lost profits.Lilly also moved for judgment as a matter of law at the close of evidence on November 8, 2023. [ECF No. 588 ]. That motion is DENIED as moot.SO ORDERED.(McManus, Caetlin) (Entered: 09/26/2023) (55) |
| Sep 26, 2023 | 696 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered. ECF Nos. 643 , MOTION for Post-Trial Relief and 655 Emergency MOTION to Strike are DENIED as moot. (McManus, Caetlin) (Entered: 09/26/2023) (0) |
| Sep 25, 2023 | 694 | Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to 693 Notice of Supplemental Authorities . (Blais, Elaine) (Entered: 09/25/2023) (4) |
| Sep 22, 2023 | 693 | Notice of Supplemental Authorities re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 (Attachments: # 1 Exhibit A)(Martin, Andrea) (Entered: 09/22/2023) (0) |
| Sep 8, 2023 | 692 | NOTICE of Withdrawal of Appearance by Autumn Soucy (Audie Soucy) (Soucy, Autumn) (Entered: 09/08/2023) (3) |
| Aug 24, 2023 | 691 | NOTICE of Withdrawal of Appearance by Andrea L. Martin Withdrawal of Li Zhang (Martin, Andrea) (Entered: 08/24/2023) (2) |
| May 24, 2023 | 690 | Notice of Supplemental Authorities re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 Response to Docket 689 (Martin, Andrea) (Entered: 05/24/2023) (4) |
| May 22, 2023 | 688 | NOTICE of Withdrawal of Appearance by Elaine Herrmann Blais Withdrawal of Sean M. Anderson (Blais, Elaine) (Entered: 05/22/2023) (3) |
| May 22, 2023 | 689 | Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to 687 Notice of Supplemental Authorities . (Blais, Elaine) (Entered: 05/22/2023) (4) |
| May 19, 2023 | 687 | Notice of Supplemental Authorities re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 (Attachments: # 1 Exhibit A)(Martin, Andrea) (Entered: 05/19/2023) (0) |
| Mar 15, 2023 | 685 | REPLY to Response to 643 MOTION for Post-Trial Relief - Redacted Public Version filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Entered: 03/15/2023) (23) |
| Mar 15, 2023 | 686 | REPLY to Response to 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 REDACTED replaced Dkt 683 filed by Eli Lilly and Company. (Martin, Andrea) (Entered: 03/15/2023) (22) |
| Mar 10, 2023 | 678 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 676 Motion to Seal Confidential Portions of the Reply in Support of Teva's Motion for Post Trial Relief. (Folan, Karen) (Entered: 03/10/2023) (0) |
| Mar 10, 2023 | 679 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 677 Motion to Seal Reply for Motion for JMOL, FRCP 50B or 59. (Folan, Karen) (Entered: 03/10/2023) (0) |
| Mar 10, 2023 | 680 | REPLY to Response to 643 MOTION for Post-Trial Relief - Filed Under Seal filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Main Document 680 replaced on 3/13/2023) (McManus, Caetlin). (Entered: 03/10/2023) (0) |
| Mar 10, 2023 | 681 | DECLARATION re 680 Reply to Response to Motion - Declaration of Robert Frederickson III in Support of Reply Memorandum in Support of Teva's Motion for Post-Trial Relief by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2 - Filed Under Seal, # 3 Exhibit 3, # 4 Exhibit 4)(Frederickson, Robert) (Attachment 2 replaced on 3/13/2023) (McManus, Caetlin). (Entered: 03/10/2023) (0) |
| Mar 10, 2023 | 682 | DECLARATION re 680 Reply to Response to Motion - Declaration of Lisa J. Cameron in Support of Reply Memorandum in Support of Teva's Motion for Post-Trial Relief - Filed Under Seal by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Main Document 682 replaced on 3/13/2023) (McManus, Caetlin). (Entered: 03/10/2023) (0) |
| Mar 10, 2023 | 683 | REPLY to Response to 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 Leave to File Granted Dkt 637 Leave to File Under Seal Dkt 679 filed by Eli Lilly and Company. (Martin, Andrea) (Main Document 683 replaced on 3/13/2023) (McManus, Caetlin). (Entered: 03/10/2023) (0) |
| Mar 10, 2023 | 684 | AFFIDAVIT of Emily Gabranski in Support re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 In support of Reply Dkt 683 filed by Eli Lilly and Company. (Attachments: # 1 Exhibit C filed under seal, # 2 Exhibit D filed under seal)(Martin, Andrea) (Attachment 1 replaced on 3/13/2023) (McManus, Caetlin). (Attachment 2 replaced on 3/13/2023) (McManus, Caetlin). (Entered: 03/10/2023) (0) |
| Mar 9, 2023 | 676 | Assented to MOTION to Seal Confidential Portions of the Reply in Support of Teva's Motion for Post Trial Relief by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) (Entered: 03/09/2023) (4) |
| Mar 9, 2023 | 677 | MOTION to Seal re Reply for Motion for JMOL, FRCP 50B or 59 by Eli Lilly and Company.(Martin, Andrea) (Entered: 03/09/2023) (3) |
| Mar 1, 2023 | 674 | Opposition re 643 MOTION for Post-Trial Relief REDACTED replaces Dkt 669 filed by Eli Lilly and Company. (Martin, Andrea) (Entered: 03/01/2023) (30) |
| Mar 1, 2023 | 675 | AFFIDAVIT of Ryan P. O'Quinn in Opposition re 643 MOTION for Post-Trial Relief REDACTED replaces Dkt 670 filed by Eli Lilly and Company. (Martin, Andrea) (Entered: 03/01/2023) (10) |
| Feb 28, 2023 | 673 | Opposition re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 - Public Redacted Version filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 02/28/2023) (30) |
| Feb 24, 2023 | 665 | Assented to MOTION to Seal re Opposition to Teva Post-Trial Brief by Eli Lilly and Company.(Martin, Andrea) (Entered: 02/24/2023) (3) |
| Feb 24, 2023 | 666 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 665 Motion to Seal. (Folan, Karen) (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 667 | Opposition re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 - Filed Under Seal filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Main Document 667 replaced on 2/27/2023) (McManus, Caetlin). (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 668 | DECLARATION re 667 Opposition to Motion Declaration of Elaine Herrmann Blais in Support of Teva's Opposition to Eli Lilly and Company's Motion for Judgment as a Matter of Law Under Fed. R. Civ. P. 50(B) and/or a New Trial Under Fed. R. Civ. P. 59 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 - Filed Under Seal, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28)(Blais, Elaine) (Attachment 15 replaced on 2/27/2023) (McManus, Caetlin). (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 669 | Opposition re 643 MOTION for Post-Trial Relief Leave to File Excess Pages Granted Dkt 637 Leave to File Under Seal Granted Dkt 666 filed by Eli Lilly and Company. (Martin, Andrea) (Main Document 669 replaced on 2/28/2023) (McManus, Caetlin). (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 670 | AFFIDAVIT of Ryan P. O'Quinn in Opposition re 643 MOTION for Post-Trial Relief Leave to File Under Seal Dkt 642 filed by Eli Lilly and Company. (Attachments: # 1 Exhibit A under seal, # 2 Exhibit B under seal, # 3 Exhibit C under seal, # 4 Exhibit D under seal, # 5 Exhibit E under seal, # 6 Exhibit F, # 7 Exhibit G)(Martin, Andrea) (Main Document 670 replaced on 2/28/2023) (McManus, Caetlin). (Attachment 1 replaced on 2/28/2023) (McManus, Caetlin). (Attachment 2 replaced on 2/28/2023) (McManus, Caetlin). (Attachment 3 replaced on 2/28/2023) (McManus, Caetlin). (Attachment 4 replaced on 2/28/2023) (McManus, Caetlin). (Attachment 5 replaced on 2/28/2023) (McManus, Caetlin). (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 671 | AFFIDAVIT of CHRISTOPHER A. VELLTURO in Opposition re 643 MOTION for Post-Trial Relief Filed Under Seal pursuant to Dkt 666 filed by Eli Lilly and Company. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Main Document 671 replaced on 2/28/2023) (McManus, Caetlin). (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 672 | NOTICE OF MANUAL FILING by Eli Lilly and Company Exhibits 3-7A to Vellturo Declaration Dkt 671 re 671 Affidavit in Opposition to Motion, (Martin, Andrea) (Entered: 02/24/2023) (3) |
| Feb 23, 2023 | 663 | Assented to MOTION to Seal Confidential Portions of Plaintiffs' Opposition to Eli Lily and Company's Motion for Judgment as a Matter of Law Under Fed. R. Civ. P. 50(B) and/or a New Trial Under Fed. R. Civ. P. 59 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) (Entered: 02/23/2023) (4) |
| Feb 23, 2023 | 664 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 663 Assented to MOTION to Seal. (McManus, Caetlin) (Entered: 02/23/2023) (0) |
| Feb 13, 2023 | 661 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 660 Motion to Seal. (Folan, Karen) (Entered: 02/13/2023) (0) |
| Feb 13, 2023 | 662 | MEMORANDUM in Opposition re 655 Emergency MOTION to Strike 646 Declaration, to Strike Cameron Declaration; Filed under seal pursuant to Dkt 653 ; Filed Under Seal pursuant to Dkt. 661 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Main Document 662 replaced on 2/13/2023) (McManus, Caetlin). (Entered: 02/13/2023) (0) |
| Feb 10, 2023 | 660 | Assented to MOTION to Seal Confidential Portions of Plaintiffs' Opposition to Eli Lilly and Company's Emergency Motion to Strike the Declaration of Lisa J. Cameron by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Frederickson, Robert) (Entered: 02/10/2023) (4) |
| Feb 9, 2023 | 657 | MEMORANDUM in Support re 643 MOTION for Post-Trial Relief Redacted Version of ECF No. 644 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Entered: 02/09/2023) (30) |
| Feb 9, 2023 | 658 | DECLARATION re 643 MOTION for Post-Trial Relief Redacted Version of ECF No. 645 Declaration of Robert Frederickson III in Support of Teva's Motion for Post-Trial Relief by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Entered: 02/09/2023) (6) |
| Feb 9, 2023 | 659 | MEMORANDUM in Support re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 REDACTED replaces Dkt 650 filed by Eli Lilly and Company. (Martin, Andrea) (Entered: 02/09/2023) (30) |
| Feb 6, 2023 | 653 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 652 Motion to Seal. (Folan, Karen) (Entered: 02/06/2023) (0) |
| Feb 6, 2023 | 654 | NOTICE of Withdrawal of Appearance by Andrea L. Martin Withdrawal of Oulu Wang (Martin, Andrea) (Entered: 02/06/2023) (3) |
| Feb 6, 2023 | 655 | Emergency MOTION to Strike 646 Declaration, to Strike Cameron Declaration; Filed under seal pursuant to Dkt 653 by Eli Lilly and Company.(Martin, Andrea) (Additional attachment(s) added on 2/7/2023: # 1 Emergeny Motion (Filed Under Seal)) (McManus, Caetlin). (Entered: 02/06/2023) (0) |
| Feb 6, 2023 | 656 | AFFIDAVIT of Ryan P. O'Quinn in Support re 655 Emergency MOTION to Strike 646 Declaration, to Strike Cameron Declaration; Filed under seal pursuant to Dkt 653 filed by Eli Lilly and Company. (Attachments: # 1 Exhibit A under seal, # 2 Exhibit B under seal, # 3 Exhibit C under seal, # 4 Exhibit D under seal, # 5 Exhibit E under seal)(Martin, Andrea) (Attachment 1 replaced on 2/7/2023) (McManus, Caetlin). (Attachment 2 replaced on 2/7/2023) (McManus, Caetlin). (Attachment 3 replaced on 2/7/2023) (McManus, Caetlin). (Attachment 4 replaced on 2/7/2023) (McManus, Caetlin). (Attachment 5 replaced on 2/7/2023) (McManus, Caetlin). (Entered: 02/06/2023) (0) |
| Feb 3, 2023 | 652 | Assented to MOTION to Seal re Motion to Strike Declaration of Lisa Cameron by Eli Lilly and Company.(Martin, Andrea) (Entered: 02/03/2023) (3) |
| Jan 27, 2023 | 640 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 639 Motion to Seal. (Folan, Karen) (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 641 | Assented to MOTION to Seal Confidential Portions of Teva's Motion for Post-Trial Relief by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Frederickson, Robert) (Entered: 01/27/2023) (4) |
| Jan 27, 2023 | 642 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 641 Motion to Seal Confidential Portions of Teva's Motion for Post-Trial Reliefc. (Folan, Karen) (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 643 | MOTION for Post-Trial Relief by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A - [Proposed] Final Judgment)(Frederickson, Robert) (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 644 | MEMORANDUM in Support re 643 MOTION for Post-Trial Relief - Filed Under Seal filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Main Document 644 replaced on 1/30/2023) (McManus, Caetlin). (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 645 | DECLARATION re 643 MOTION for Post-Trial Relief Declaration of Robert Frederickson III in Support of Teva's Motion for Post-Trial Relief - Filed Under Seal by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 - Filed Under Seal, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8 - Filed Under Seal, # 9 Exhibit 9 - Filed Under Seal, # 10 Exhibit 10 - Filed Under Seal, # 11 Exhibit 11 - Filed Under Seal, # 12 Exhibit 12 - Filed Under Seal, # 13 Exhibit 13 - Filed Under Seal, # 14 Exhibit 14 - Filed Under Seal, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19 - Filed Under Seal, # 20 Exhibit 20 - Filed Under Seal)(Frederickson, Robert) (Main Document 645 replaced on 1/30/2023) (McManus, Caetlin). (Attachment 4 , Attachments 8-14, Attachments 19-20 replaced on 1/30/2023) (McManus, Caetlin). (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 646 | DECLARATION re 643 MOTION for Post-Trial Relief Declaration of Lisa J. Cameron in Support of Teva's Motion for Post-Trial Relief - Filed Under Seal by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3-4 - Notice of Filing with Clerk's Office)(Frederickson, Robert) (Main Document 646 replaced on 1/30/2023) (McManus, Caetlin). (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 647 | BILL OF COSTS by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A - Filed Under Seal, # 2 Exhibit B - Filed Under Seal, # 3 Exhibit C - Filed Under Seal, # 4 Exhibit D - Filed Under Seal, # 5 Exhibit E - Filed Under Seal, # 6 Exhibit F - Filed Under Seal, # 7 Exhibit G - Filed Under Seal)(Frederickson, Robert) (Attachments 1-7 replaced on 1/30/2023) (McManus, Caetlin). (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 648 | DECLARATION re 647 Bill of Costs, Declaration of Robert Frederickson III in Support of Teva's Bill of Costs - Filed Under Seal by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) (Main Document 648 replaced on 1/30/2023) (McManus, Caetlin). (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 649 | MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 by Eli Lilly and Company.(Martin, Andrea) (Entered: 01/27/2023) (3) |
| Jan 27, 2023 | 650 | MEMORANDUM in Support re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 Leave to File Excess Pages Granted 12.30.22 Leave to File Under Seal Granted 1.27.23 filed by Eli Lilly and Company. (Martin, Andrea) (Main Document 650 replaced on 1/30/2023) (McManus, Caetlin). (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 651 | AFFIDAVIT of Emily Gabranski in Support re 649 MOTION for Judgment as a Matter of Law FRCP 50(B) AND/OR A NEW TRIAL FRCP 59 filed by Eli Lilly and Company. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Martin, Andrea) (Entered: 01/27/2023) (0) |
| Jan 26, 2023 | 639 | Assented to MOTION to Seal re JMOL, Leave to File Granted 12.30.22 by Eli Lilly and Company.(Martin, Andrea) (Entered: 01/26/2023) (3) |
| Dec 30, 2022 | 637 | Judge Allison D. Burroughs: ORDER entered granting 636 Joint MOTION for Post-Trial Briefing Schedule and Entry of Judgment. (McManus, Caetlin) (Entered: 12/30/2022) (5) |
| Dec 30, 2022 | 638 | Judge Allison D. Burroughs: ORDER entered. JUDGMENT for the plaintiffs Teva PharmaceuticalsInternational GmbH and Teva Pharmaceuticals USA, Inc. (collectively, Teva) against thedefendant Eli Lilly and Company. (McManus, Caetlin) (Entered: 12/30/2022) (4) |
| Dec 29, 2022 | 636 | Joint MOTION Post-Trial Briefing Schedule and Entry of Judgment by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A - Proposed Final Judgment)(Blais, Elaine) (Entered: 12/29/2022) (0) |
| Dec 27, 2022 | 627 | REDACTED Transcript of JURY TRIAL DAY 5 held on October 24, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (218) |
| Dec 27, 2022 | 628 | REDACTED Transcript of JURY TRIAL DAY 6 held on October 25, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (198) |
| Dec 27, 2022 | 629 | REDACTED Transcript of JURY TRIAL DAY 7 held on October 26, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (209) |
| Dec 27, 2022 | 630 | REDACTED Transcript of JURY TRIAL DAY 8 held on October 27, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (232) |
| Dec 27, 2022 | 631 | REDACTED Transcript of JURY TRIAL DAY 9 held on October 28, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (223) |
| Dec 27, 2022 | 632 | REDACTED Transcript of JURY TRIAL DAY 13 held on November 3, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (290) |
| Dec 27, 2022 | 633 | REDACTED Transcript of JURY TRIAL DAY 14 held on November 4, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (332) |
| Dec 27, 2022 | 634 | REDACTED Transcript of JURY TRIAL DAY 16 held on November 8, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 1/17/2023. Redacted Transcript Deadline set for 1/27/2023. Release of Transcript Restriction set for 3/27/2023. (McDonagh, Christina) (Entered: 12/27/2022) (82) |
| Dec 27, 2022 | 635 | NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (McDonagh, Christina) (Entered: 12/27/2022) (0) |
| Dec 8, 2022 | 623 | REDACTED Transcript of Jury Trial - Day 12 held on November 2, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 12/29/2022. Redacted Transcript Deadline set for 1/9/2023. Release of Transcript Restriction set for 3/8/2023. (McDonagh, Christina) (Entered: 12/08/2022) (246) |
| Dec 8, 2022 | 625 | REDACTED Transcript of Jury Trial - Day 10 held on October 31, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 12/29/2022. Redacted Transcript Deadline set for 1/9/2023. Release of Transcript Restriction set for 3/8/2023. (McDonagh, Christina) (Entered: 12/08/2022) (188) |
| Dec 8, 2022 | 626 | NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (McDonagh, Christina) (Entered: 12/08/2022) (0) |
| Dec 7, 2022 | 622 | Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 621 Joint MOTION to Redact transcript. (Folan, Karen) (Entered: 12/07/2022) (0) |
| Dec 5, 2022 | 620 | Transcript Redaction Request re 613 Transcript, 610 Transcript, 612 Transcript, by attorney Andrea L. Martin. (Martin, Andrea) (Entered: 12/05/2022) (0) |
| Dec 5, 2022 | 621 | Joint MOTION to Redact 605 Transcript, 608 Transcript, 607 Transcript,, 616 Transcript, 606 Transcript,, 613 Transcript, 609 Transcript, 614 Transcript,, by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Proposed Redactions - Trial Transcript Day 5, # 2 Proposed Redactions - Trial Transcript Day 6, # 3 Proposed Redactions - Trial Transcript Day 7, # 4 Proposed Redactions - Trial Transcript Day 8, # 5 Proposed Redactions - Trial Transcript Day 9, # 6 Proposed Redactions - Trial Transcript Day 13, # 7 Proposed Redactions - Trial Transcript Day 14, # 8 Proposed Redactions - Trial Transcript Day 16)(Blais, Elaine) (Entered: 12/05/2022) (0) |
| Nov 23, 2022 | 619 | NOTICE of Intent to Request Redaction by Andrea L. Martin re 613 Transcript, 610 Transcript, 612 Transcript, (Martin, Andrea) (Entered: 11/23/2022) (2) |
| Nov 14, 2022 | 600 | Transcript of Jury Trial - Day 1 held on October 18, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 11/30/2022. Redacted Transcript Deadline set for 12/12/2022. Release of Transcript Restriction set for 2/7/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (0) |
| Nov 14, 2022 | 602 | Transcript of Jury Trial - Day 2 held on October 19, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com and Rachel Lopez. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (189) |
| Nov 14, 2022 | 603 | Transcript of Jury Trial - Day 3 held on October 20, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com and Joan Daly. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (204) |
| Nov 14, 2022 | 604 | Transcript of Jury Trial - Day 4 held on October 21, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (219) |
| Nov 14, 2022 | 611 | Transcript of Jury Trial - Day 11 held on November 1, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com and Kristin Kelley. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (179) |
| Nov 14, 2022 | 615 | Transcript of Jury Trial - Day 15 held on November 7, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com and Kristin Kelley. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (225) |
| Nov 14, 2022 | 617 | Transcript of Jury Trial - Day 17 held on November 9, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com and Kristin Kelley. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Coppola, Katelyn) (Entered: 11/16/2022) (11) |
| Nov 14, 2022 | 618 | NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Coppola, Katelyn) (Entered: 11/18/2022) (0) |
| Nov 9, 2022 | N/A | Jury Trial - Completed (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 17 held on 11/9/2022. Jury deliberations resume. Jury returns verdict. (Court Reporter: Kristin Kelley at kmob929@gmail.com.) (Folan, Karen) |
| Nov 9, 2022 | 593 | Jury Verdict (10) Docket Text: JURY VERDICT entered. (Folan, Karen) |
| Nov 9, 2022 | N/A | Remark (0) Docket Text: Trial exhibits returned to parties. (Folan, Karen) |
| Nov 9, 2022 | 594 | Trial exhibits returned to parties. (Folan, Karen) (Entered: 11/10/2022) (0) |
| Nov 9, 2022 | 601 | NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Coppola, Katelyn) (Entered: 11/16/2022) (0) |
| Nov 8, 2022 | 588 | Motion for Judgment as a Matter of Law (27) Docket Text: MOTION for Judgment as a Matter of Law FRCP 50(A) by Eli Lilly and Company.(Martin, Andrea) |
| Nov 8, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 16 held on 11/8/2022. Closing arguments by the parties. Jury instructions given. Jury begin deliberations. (Court Reporter: Debra Joyce at joycedebra@gmail.com) (Folan, Karen) |
| Nov 7, 2022 | 585 | Stipulation (5) Docket Text: STIPULATION (Joint) Stipulation and [Proposed] Order Regarding Inequitable Conduct and Unclean Hands by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Nov 7, 2022 | 586 | Order (5) Docket Text: Judge Allison D. Burroughs: ORDER entered APPROVING [585] Stipulation and Order Regarding Inequitable Conduct and Unclean Handsfiled by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| Nov 7, 2022 | 587 | Objection (5) Docket Text: Objection by Eli Lilly and Company TO FINAL JURY INSTRUCTIONS AND JURY VERDICT FORM. (Martin, Andrea) |
| Nov 7, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 15 held on 11/7/2022. Testimony of Raymond Hill resumes. Video deposition testimony of Dr. Benschop, Geoffrey Hale sworn and testifies. Teva rests. Court gives of jury instructions. (Court Reporter: Debra Joyce at joycedebra@gmail.com and Kristin Kelley at kmob929@gmail.com) (Folan, Karen) |
| Nov 6, 2022 | 583 | Brief (6) Docket Text: BRIEF by Eli Lilly and Company SUPPLEMENTAL BRIEF REGARDING THE JURY CHARGE. (Martin, Andrea) |
| Nov 6, 2022 | 584 | Response (7) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [583] Brief Supplemental Brief Regarding the Jury Charge. (Blais, Elaine) |
| Nov 4, 2022 | 582 | Brief (4) Docket Text: BRIEF by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. Bench Brief Concerning Patent Assignment Law and Standing. (Blais, Elaine) |
| Nov 4, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 14 held on 11/4/2022. Testimony of Laura Happe resumes. Video deposition of Gordon Brooks, Christopher Vellturo sworn and testifies. Lilly rests. Teva calls Dr. Blumenfeld - sworn and testifies. Raymond Hill sworn and testifies. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.) (Folan, Karen) |
| Nov 3, 2022 | 574 | Brief (8) Docket Text: BRIEF by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. Bench Brief Concerning Statements by Third Parties. (Blais, Elaine) |
| Nov 3, 2022 | 576 | Proposed Jury Instructions (3) Docket Text: Supplemental Proposed Jury Instructions by Eli Lilly and Company. (Martin, Andrea) |
| Nov 3, 2022 | 577 | Proposed Jury Instructions (3) Docket Text: Proposed Jury Instructions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Nov 3, 2022 | N/A | Order on Motion for Miscellaneous Relief (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. Tevas motion to exclude Lillys experts from testifying concerning post-filing experimentation, [ECF No. [569]], is DENIED for the reasons set forth on the record. The Court adds that evidence of post-filing experimentation is admissible to the validity inquiry as it pertains to the amount of experimentation necessary practice the claimed invention. See Amgen Inc. v. Sanofi, 872 F.3d 1367, 1375 (Fed. Cir. 2017); MorphoSys AG v. Janssen Biotech, Inc., 358 F. Supp. 3d 354, 365 (D. Del. 2019). That Lillys researchers testified that they were not aware of the asserted patents for at least part of the time they worked to invent the accused product goes to the weight accorded to evidence of Lillys experimentation, but it does not categorically preclude introduction of said evidence. (McManus, Caetlin) |
| Nov 3, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 13 held on 11/3/2022. Testimony of Andrew Charles resumes. Testimony of Sarah Walter by video testimony. Diane Mould, Ryan Pettibone, Cory Rotterman sworn and testify. Testimony of Jason Daly by video deposition. Laura Happe sworn and testifies. (Court Reporter: Debra Joyce at joycedebra@gmail.com and Kristin Kelley at kmob929@gmail.com) (Folan, Karen) |
| Nov 2, 2022 | 569 | Motion for Miscellaneous Relief (6) Docket Text: MOTION to Exclude Lilly's Experts from Testifying Concerning Post-Filing Experimentation by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Nov 2, 2022 | 570 | Proposed Document(s) submitted (4) Docket Text: Proposed Document(s) submitted by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. Document received: November 1, 2022. (Blais, Elaine) |
| Nov 2, 2022 | 571 | Brief (11) Docket Text: BRIEF by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. Concerning the Final Jury Instruction on the 35 U.S.C. Section 112 Written Description Requirement. (Blais, Elaine) |
| Nov 2, 2022 | 572 | Proposed Jury Instructions (5) Docket Text: Proposed Jury Instructions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Nov 2, 2022 | 573 | Response (6) Docket Text: Response by Eli Lilly and Company to [571] Brief CONCERNING THE FINAL JURY INSTRUCTION ON THE 35 U.S.C. § 112 WRITTEN DESCRIPTION REQUIREMENT. (Martin, Andrea) |
| Nov 2, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 12 held on 11/2/2022. Testimony of James McDonnell resumes. Video testimony of Dr. Douglas Harnish. Andrew Charles sworn and testifies. Testimony of Marcelo Bigal by video deposition. Testimony of Jaume Pons by video deposition. (Court Reporter: Debra Joyce at joycedebra@gmail.com and Kristin Kelley at kmob929@gmail.com) (Folan, Karen) |
| Nov 1, 2022 | 567 | Opposition to Motion (5) Docket Text: Opposition re [481] MOTION in Limine (Omnibus) Opposition to Teva's Motion to Exclude Post Filing Experimentation [orally made in Court 10.31.22] filed by Eli Lilly and Company. (Martin, Andrea) |
| Nov 1, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 11 held on 11/1/2022. Video deposition of Dr. Rosenthal. Stipulation of facts read to the jury. James McDonnell sworn and testifies. (Court Reporter: Kristin Kelley at kmob929@gmail.com and Debra Joyce at joycedebra@gmail.com) (Folan, Karen) |
| Oct 31, 2022 | 565 | Letter/request (non-motion) (3) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais re Trial Length. (Blais, Elaine) |
| Oct 31, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 10 held on 11/1/2022. Testimony of Ryan Darling resumes. Video deposition testimony by Robert Conley. Catherine Ramseyer sworn and testifies. Video deposition testimony of Jennifer Stratton and Kristian Poulsen. (Court Reporter: Kristin Kelley at kmob929@gmail.com and Debra Joyce at joycedebra@gmail.com) (Folan, Karen) Modified on 11/1/2022 to correct hearing date (Folan, Karen). |
| Oct 28, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 9 held on 10/28/2022. Defendant files motion - Motion denied with leave to renew. Laura Steele sworn and testifies. Testimony of Mark Benschop resumes. Video testimony of Kalpana Merchant and Barrett Allan. Ryan Darling sworn and testifies. (Court Reporter: Kristin Kelley at kmob929@gmail.com and Debra Joyce at joycedebra@gmail.com) (Folan, Karen) |
| Oct 27, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 8 held on 10/27/2022. Testimony of Mark Berkman resumes. Teva rests. Robert Benschop sworn and testifies. (Court Reporter: Debra Joyce at joycedebra@gmail.com and Kristin Kelley at kmob929@gmail.com.) (Folan, Karen) |
| Oct 26, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 7 held on 10/26/2022. Elan Rubenstein sworn and testifies. Video deposition testimony of Ryan Pettibone. Mark Berkman sworn and testifies. (Court Reporter: Debra Joyce at joycedebra@gmail.com and Kristin Kelley at kmob929@gmail.com.) (Folan, Karen) |
| Oct 25, 2022 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [557], [558] and [559] Motions for Leave to Appear Pro Hac Vice of Gabriel B. Ferrante, Autumn Soucy and Grace P. Truong. Attorneys admitted Pro Hac Vice must have an individual PACER account, not a shared firm account, to electronically file in the District of Massachusetts. To register for a PACER account, go the Pacer website at https://pacer.uscourts.gov/register-account. You must put the docket number on your form when registering or it will be rejected.Pro Hac Vice Admission Request Instructions https://www.mad.uscourts.gov/caseinfo/nextgen-pro-hac-vice.htm.A Notice of Appearance must be entered on the docket by the newly admitted attorney. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause.(McManus, Caetlin) |
| Oct 25, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 6 held on 10/25/2022. Testimony of Brian Mauk resumes. Sharon Hausdorff sworn and testifies. Video deposition testimony of Gordon Brooks and Corey Rotterman. (Court Reporter: Debra Joyce at joycedebra@gmail.com and Robert Paschal at rwp.reporter@gmail.com) (Folan, Karen) |
| Oct 24, 2022 | N/A | Order on Motion for Miscellaneous Relief (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting in part [552] Motion for a Curative Instruction. Although not totally clear that a curative instructive was warranted, out of an abundance of caution, the Court gave a modified version of the instruction requested by Plaintiffs, without objection from Defendant. (Folan, Karen) |
| Oct 24, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 5 held on 10/24/2022. Testimony of Pamela Blake resumes. Tom Rainey and Brain Mauk sworn and testify. (Court Reporter: Debra Joyce at joycedebra@gmail.comand Robert Paschal at rwp.reporter@gmail.com) (Folan, Karen) |
| Oct 23, 2022 | 552 | Motion for Miscellaneous Relief (11) Docket Text: Emergency MOTION Curative Instruction by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 21, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 4 held on 10/21/2022. Jeffrey Ravetch testimony resumes. Video deposition testimony of Robert Connolly and Laura Steele. Pamela Blake sworn and testifies. (Court Reporter: Rachel Lopez at raeufp@gmail.com and Kristin Kelley) (Folan, Karen) |
| Oct 20, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 3 held on 10/20/2022. Testimony of Dr. Zeller resumes. Dr. Abdiche sworn and testifies. Video testimony of Dr. Allen, Robert Benshaw, Mark Chambers, Ryan Darling, and Katherine Ramseyer. Jeffrey Ravetch sworn and testifies. (Court Reporter: Joan Daly and Debra Joyce at joycedebra@gmail.com.) (Folan, Karen) |
| Oct 19, 2022 | 546 | Opposition to Motion (6) Docket Text: Opposition re [538] Emergency MOTION for Reconsideration re [535] Memorandum & ORDER,, [474] MOTION in Limine Lilly MIL 2 re Bergerot filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 19, 2022 | N/A | Order on Motion for Reconsideration (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. For the reasons stated on the record, Defendant's emergency motion to reconsider, [ECF No. [538]], is DENIED. (McManus, Caetlin) |
| Oct 19, 2022 | N/A | Jury Trial - Held (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 2 held on 10/19/2022.The Court heard arguments on stipulations and allowing jurors to prepare questions during the trial. The Court notified the parties of stipulations and allowing questions to be prepared during the trial. Opening statements heard by both parties, Atty. Kline for Plaintiffs and Atty. Lipsey for Defendant. The Court took a break and commenced evidence in afternoon session. Case recalled. Plaintiff's evidence commenced with examination of (1) Arnon Rosenthal. Witness sworn, direct examination, cross, and re-direct. Plaintiffs then called (2) Jorg Zeller. Witness sworn, direct examination. Direct examination to resume October 20, 2022. Jury excused. Morning session covered by M. Montes; afternoon session covered by M. Lara. (Court Reporter: Debra Joyce at joycedebra@gmail.com for MORNING SESSION; Rachel Lopez at raeufp@gmail.com for AFTERNOON SESSION)(Attorneys present: Elaine Blais, Douglas Kline for Plaintiffs; Charles Lipsey, Pier DeRoo, and Andrea Martin for Defendant) (Lara, Miguel) |
| Oct 18, 2022 | 536 | Stipulation (21) Docket Text: STIPULATION Corrected (Joint) Stipulation Regarding Trial Procedures by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 18, 2022 | 537 | Stipulation (5) Docket Text: STIPULATION (Joint) Stipulation Regarding Authenticity of Financial Documents by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 18, 2022 | 538 | Motion for Reconsideration (5) Docket Text: Emergency MOTION for Reconsideration re [535] Memorandum & ORDER,, [474] MOTION in Limine Lilly MIL 2 re Bergerot by Eli Lilly and Company.(Martin, Andrea) |
| Oct 18, 2022 | 540 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Michael Kendall on behalf of Pfizer Inc. (Kendall, Michael) |
| Oct 18, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [541] Motion to Impound Highly Confidential Pfizer Materials at Trial and Redact Portions of Trial Transcript Referencing Such Materials. (Folan, Karen) |
| Oct 18, 2022 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered APPROVING [536] Stipulation Regarding Trial Procedures filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (McManus, Caetlin) |
| Oct 18, 2022 | 544 | Order (5) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered APPROVING [537] Stipulation Regarding Authenticity of Financial Documents filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (McManus, Caetlin) |
| Oct 18, 2022 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. Plaintiffs have filed motions to exclude the testimony of Dr. Diane Mould, [ECF No. [319]], certain opinions of James M. McDonnell, Ph.D., [ECF No. [322]], and certain opinions of Dr. Andrew Charles, [ECF No. [325]]. Defendant, in turn, has moved to partially exclude the testimony of Dr. Elan Rubinstein and Dr. Mark Berman. [ECF No. [310]]. Because the Court finds that the arguments raised in the motions largely go to the weight rather than the admissibility of the opinions sought to be offered, they are DENIED. Each of the proffered experts may testify at trial subject to proper objections at trial. (McManus, Caetlin) |
| Oct 18, 2022 | N/A | Jury Trial - Begun (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Jury Trial Day 1 held on 10/18/2022. Jury of 12 selected and sworn. Preliminary instructions given. (Court Reporter: Debra Joyce at joycedebra@gmail.com.) (Folan, Karen) |
| Oct 17, 2022 | 530 | Stipulation (6) Docket Text: STIPULATION (Joint) Stipulation and [Proposed] Order Regarding Asserted Claims by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 17, 2022 | 531 | Order (6) Docket Text: Judge Allison D. Burroughs: ORDER entered APPROVING [530] Stipulation regarding asserted claims filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| Oct 17, 2022 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [532] Motion for Leave to Appear Pro Hac Vice Added J. Michael Jakes. Attorneys admitted Pro Hac Vice must have an individual upgraded PACER account, not a shared firm account, to electronically file in the District of Massachusetts. Counsel may need to link their CM/ECF account to their upgraded individual pacer account. Instructions on how to link CM/ECF accounts to upgraded pacer account can be found at https://www.mad.uscourts.gov/caseinfo/nextgen-current-pacer-accounts.htm#link-account. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McManus, Caetlin) |
| Oct 17, 2022 | 534 | Stipulation (20) Docket Text: STIPULATION (Joint) Stipulation Regarding Trial Procedures by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 17, 2022 | 535 | Memorandum & ORDER (20) Docket Text: Judge Allison D. Burroughs: MEMORANDUM AND ORDER on Motions in Limine entered. These motions in limine are resolved as follows: •Tevas MIL No. 12 is GRANTED; •Tevas MIL Nos. 2, 4, and 10 are GRANTED in part and DENIED in part; •Tevas MIL No. 1, 3, 5, 6, 7, 8, 9, 11, 13 and 14 are DENIED; •Lillys MIL No. 3, [ECF No. [476]], is GRANTED; and • Lillys MIL Nos. 1, 2, 4, 5, 6 and 7, [ECF Nos. [472], [474], [477], [478], [479], and [480]], are DENIED.SO ORDERED.(McManus, Caetlin) |
| Oct 16, 2022 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. Defendant’s request for leave to depose Bryan Mauk, [ECF No. [491]], is GRANTED. Plaintiffs are further ordered to make Mauk available at the earliest mutually convenient time. Although the substitution of Mauk as a trial witness in lieu of another employee who was deposed in this matter appears to be an unforeseen and unfortunate necessity, Defendant was not responsible for that change and it would be inappropriate to require Defendant to bear the brunt of the associated adverse consequences. The Court further DENIES as moot Defendant’s motion in limine to preclude Mauk’s testimony, [ECF No. [482]], with leave to renew if warranted.(McManus, Caetlin) |
| Oct 14, 2022 | 528 | Order (6) Docket Text: Judge Allison D. Burroughs: ORDER entered APPROVING [527] Stipulation filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| Oct 13, 2022 | 527 | Stipulation (6) Docket Text: STIPULATION re [381] Order Joint Stipulation Amending Protective Order by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 12, 2022 | 526 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Li Zhang on behalf of Eli Lilly and Company (Zhang, Li) |
| Oct 11, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [516] Motion to Seal. (Folan, Karen) |
| Oct 11, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [518] Motion to Seal. (Folan, Karen) |
| Oct 11, 2022 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [519] Motion for Leave to Appear Pro Hac Vice Added Sydney R. Kestle. Attorneys admitted Pro Hac Vice must have an individual PACER account, not a shared firm account, to electronically file in the District of Massachusetts. To register for a PACER account, go the Pacer website at https://pacer.uscourts.gov/register-account.Pro Hac Vice Admission Request Instructions https://www.mad.uscourts.gov/caseinfo/nextgen-pro-hac-vice.htm.A Notice of Appearance must be entered on the docket by the newly admitted attorney. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McManus, Caetlin) |
| Oct 10, 2022 | 516 | Motion to Seal (3) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' Trial Brief by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 10, 2022 | 517 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Kevin P. Martin on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Martin, Kevin) |
| Oct 10, 2022 | 518 | Motion to Seal (3) Docket Text: Assented to MOTION to Seal Portions of Lilly's Trial Briefs by Eli Lilly and Company.(Martin, Andrea) |
| Oct 6, 2022 | N/A | Pretrial Conference - Final (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Final Pretrial Conference held on 10/6/2022. Parties would like a daily transcript during the trial. Empanelment will begin on the 18th and court will select 12 jurors. Patent video will be shown before openings. Colloquy re: pending motion. (Court Reporter: Joan Daly at joanmdaly62@gmail.com.) (Folan, Karen) |
| Oct 4, 2022 | 514 | Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance by I. Neel Chatterjee (Chatterjee, I.) |
| Oct 3, 2022 | 513 | Memorandum & ORDER (53) Docket Text: Judge Allison D. Burroughs: MEMORANDUM AND ORDER entered. Lilly’s motions for summary judgment for lack of enablement, insufficient written description, and no willful infringement are DENIED, its partial motion for summary judgment for non-infringement is GRANTED and Teva’s motions for summary judgment regarding judicial estoppel and inequitable conduct are DENIED.SO ORDERED.(McManus, Caetlin) |
| Sep 29, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [495] Motion to Seal Confidential Portions of Joint Pretrial Memorandum. (Folan, Karen) |
| Sep 29, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [496] Motion to Seal re Opposition to Omnibus Motion in Limine. (Folan, Karen) |
| Sep 29, 2022 | 499 | Motion to Seal (4) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' Oppositions to Lilly's Motions in Limine by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Sep 29, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [499] Motion to Seal Confidential Portions of Plaintiffs' Oppositions to Lilly's Motions in Limine. (Folan, Karen) |
| Sep 29, 2022 | 505 | Memorandum in Opposition to Motion (8) Docket Text: MEMORANDUM in Opposition re [476] MOTION in Limine Lilly MIL 3 re Presumption of Validity filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Sep 29, 2022 | 508 | Memorandum in Opposition to Motion (11) Docket Text: MEMORANDUM in Opposition re [479] MOTION in Limine Lilly MIL 6 re Prevalence of Migraine Clinical filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Sep 29, 2022 | 510 | Memorandum in Opposition to Motion (10) Docket Text: MEMORANDUM in Opposition re [482] MOTION in Limine Lilly MIL 8 re Bryan Mauk filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Sep 28, 2022 | 495 | Motion to Seal (5) Docket Text: Joint MOTION to Seal Confidential Portions of Joint Pretrial Memorandum by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Sep 28, 2022 | 496 | Motion to Seal (5) Docket Text: Assented to MOTION to Seal re Opposition to Omnibus Motion in Limine by Eli Lilly and Company.(Martin, Andrea) |
| Sep 21, 2022 | 494 | Response (3) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [491] Letter/request (non-motion), re Brian Mauk Deposition. (Frederickson, Robert) |
| Sep 19, 2022 | 487 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Molly Grammel on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Grammel, Molly) |
| Sep 19, 2022 | 488 | Motion to Seal (3) Docket Text: Assented to MOTION to Seal re Letter to Court re Bryan Mauk by Eli Lilly and Company.(Martin, Andrea) |
| Sep 19, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [488] Motion to Seal. (Folan, Karen) |
| Sep 19, 2022 | 490 | Notice (Other) (17) Docket Text: NOTICE by Eli Lilly and Company Pursuant to 35 U.S.C. § 282 (Martin, Andrea) |
| Sep 16, 2022 | 468 | Motion to Seal (4) Docket Text: Assented to MOTION to Seal and for Leave to Impound Confidential Portions of Plaintiffs' Omnibus Motion in Limine by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Sep 16, 2022 | N/A | Order on Motion for Leave to File Excess Pages (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [466] Motion for Leave to File Excess Pages ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Sep 16, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [467] Motion to Seal. (Folan, Karen) |
| Sep 16, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [468] Motion to Seal and for Leave to Impound Confidential Portions of Plaintiffs' Omnibus Motion in Limine. (Folan, Karen) |
| Sep 16, 2022 | 472 | Motion in Limine (3) Docket Text: MOTION in Limine Lilly MIL 1 re Judicial Estoppel by Eli Lilly and Company.(Martin, Andrea) |
| Sep 16, 2022 | 474 | Motion in Limine (3) Docket Text: MOTION in Limine Lilly MIL 2 re Bergerot by Eli Lilly and Company.(Martin, Andrea) |
| Sep 16, 2022 | 476 | Motion in Limine (8) Docket Text: MOTION in Limine Lilly MIL 3 re Presumption of Validity by Eli Lilly and Company.(Martin, Andrea) |
| Sep 16, 2022 | 482 | Motion in Limine (3) Docket Text: MOTION in Limine Lilly MIL 8 re Bryan Mauk by Eli Lilly and Company.(Martin, Andrea) |
| Sep 15, 2022 | 466 | Motion for Leave to File Excess Pages (3) Docket Text: Assented to MOTION for Leave to File Excess Pages For Motions in Limine by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Sep 15, 2022 | 467 | Motion to Seal (6) Docket Text: Assented to MOTION to Seal re Motions in Limine by Lilly by Eli Lilly and Company.(Martin, Andrea) |
| Sep 12, 2022 | N/A | Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Coppola, Katelyn) |
| Sep 7, 2022 | 462 | Exhibit (30) Docket Text: EXHIBIT re [296] Affidavit in Support of Motion,,,,,,,,,,,,, CORRECTED Exhibit to Replace Dkt 296-14 [Ex 62] by Eli Lilly and Company. (Martin, Andrea) |
| Sep 7, 2022 | N/A | Hearing (Other) (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Hearing held on 9/7/2022. Oral arguments by the parties. Court takes matter under advisement. (Court Reporter: Kelly Mortellite at mortellite@gmail.com and Kristin Kelley) (Folan, Karen) |
| Sep 6, 2022 | 461 | Response (2) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [460] Letter/request (non-motion) regarding proposed use of confidential information at September 7, 2022 Summary Judgment Hearing. (Blais, Elaine) |
| Sep 2, 2022 | 460 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Eli Lilly re disclosure of confidential information. (Martin, Andrea) |
| Sep 2, 2022 | N/A | Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Coppola, Katelyn) |
| Sep 1, 2022 | 458 | Letter/request (non-motion) (2) Docket Text: Joint Letter/request (non-motion) from Elaine Herrmann Blais regarding summary judgment hearing. (Blais, Elaine) |
| Sep 1, 2022 | 459 | Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance of Mark J. Stewart (Martin, Andrea) Modified on 9/2/2022 to reflect correct attorney withdrawal is for (Currie, Haley). |
| Aug 15, 2022 | N/A | Hearing (Other) (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Motion Hearing held on 8/15/2022. Oral arguments by the parties. Motion Hearing continued and set for 9/7/2022 10:00 AM in Courtroom 17 (In person only) before Judge Allison D. Burroughs. (Court Reporter: Joan Daly at joanmdaly62@gmail.com.) (Folan, Karen) |
| Aug 3, 2022 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. In response to the letter from Teva regarding the upcoming trial schedule [ECF No. 416], the court advises the parties as follows: Trial will begin on October 18, 2022 and should end by November 10, 2022. The trial day will generally be 10 am to 4 pm with a lunch break from 12-12:45 and another break from 2:15-2:30. If feasible, we may do one half day per week, which would run from 9 am-1:00 pm with a short break at 11. The half days will be determined as we go with input from jury and attorneys, but likely half days will be 10/31 (Halloween), 11/1 (monthly judges' meeting) and 11/8 (election day). (Folan, Karen) |
| Jul 28, 2022 | 448 | Reply to Response to Motion (16) Docket Text: REPLY to Response to [417] MOTION for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Version of ECF No. 301 - Public Redacted Version of ECF No. 386 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 28, 2022 | 449 | Statement of Material Facts L.R. 56.1 (30) Docket Text: Statement of Material Facts L.R. 56.1 re [417] MOTION for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Version of ECF No. 301 Reply Statement of Material Facts in Support of Plaintiffs' Motion for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Redacted Version of ECF No. 387 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 28, 2022 | 450 | Reply to Response to Motion (16) Docket Text: REPLY to Response to [423] MOTION for Partial Summary Judgment Regarding Judicial Estoppel - Public Redacted Version of ECF No. 314 - Public Redacted Version of ECF No. 388 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 28, 2022 | 451 | Statement of Material Facts L.R. 56.1 (30) Docket Text: Statement of Material Facts L.R. 56.1 re [423] MOTION for Partial Summary Judgment Regarding Judicial Estoppel - Public Redacted Version of ECF No. 314 Reply Statement of Material Facts in Support of Plaintiffs' Motion for Partial Summary Judgment Regarding Judicial Estoppel - Public Redacted Version of ECF No. 389 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 28, 2022 | 452 | Reply to Response to Motion (16) Docket Text: REPLY to Response to [428] MOTION to Exclude the Expert Testimony of Dr. Diane R. Mould - Public Redacted Version of ECF No. 319 - Public Redacted Version of ECF No. 390 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 28, 2022 | 453 | Reply to Response to Motion (15) Docket Text: REPLY to Response to [431] MOTION to Exclude Certain Opinions of Defendant's Expert James McDonnell, PH.D. - Public Redacted Version of ECF No. 322 - Public Redacted Version of ECF No. 391 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 28, 2022 | 455 | Reply to Response to Motion (16) Docket Text: REPLY to Response to [434] MOTION to Exclude Certain Opinions of Defendant's Expert Dr. Andrew Charles - Public Redacted Version of ECF No. 325 - Public Redacted Version of ECF No. 393 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 418 | Memorandum in Support of Motion (26) Docket Text: MEMORANDUM in Support re [417] MOTION for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Version of ECF No. 301 Public Redacted Version of ECF No. 302 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 419 | Statement of Material Facts L.R. 56.1 (10) Docket Text: Statement of Material Facts L.R. 56.1 re [417] MOTION for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Version of ECF No. 301 Public Redacted Version of ECF No. 303 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 421 | Declaration (3) Docket Text: DECLARATION re [417] MOTION for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Version of ECF No. 301 Expert Declaration of Geoffrey Hale PH.D. - Public Redacted Version of ECF No. 309 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 422 | Declaration (3) Docket Text: DECLARATION re [417] MOTION for Summary Judgment of No Inequitable Conduct and Unclean Hands - Public Version of ECF No. 301 Expert Declaration of Raymond Hill, PH.D - Public Redacted Version of ECF No. 312 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 424 | Memorandum in Support of Motion (27) Docket Text: MEMORANDUM in Support re [423] MOTION for Partial Summary Judgment Regarding Judicial Estoppel - Public Redacted Version of ECF No. 314 Public Redacted Version of ECF 315 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 425 | Statement of Material Facts L.R. 56.1 (16) Docket Text: Statement of Material Facts L.R. 56.1 re [423] MOTION for Partial Summary Judgment Regarding Judicial Estoppel - Public Redacted Version of ECF No. 314 Public Redacted Version of ECF 316 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | N/A | Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Hearing on Motion [305] MOTION for Partial Summary Judgment No Willful Infringement, [314] MOTION for Partial Summary Judgment, [289] MOTION for Summary Judgment Invalidity for Lack of Enablement, [293] MOTION for Summary Judgment Invalidity for Lack of Written Description, [301] MOTION for Summary Judgment, [297] MOTION for Partial Summary Judgment Non Infringement Doctrine of Equivalents : Motion Hearing set for 8/15/2022 10:00 AM in Courtroom 17 (In person only) before Judge Allison D. Burroughs. (Folan, Karen) |
| Jul 27, 2022 | 429 | Memorandum in Support of Motion (22) Docket Text: MEMORANDUM in Support re [428] MOTION to Exclude the Expert Testimony of Dr. Diane R. Mould - Public Redacted Version of ECF No. 319 - Public Redacted Version of ECF No. 320 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 430 | Declaration (3) Docket Text: DECLARATION re [428] MOTION to Exclude the Expert Testimony of Dr. Diane R. Mould - Public Redacted Version of ECF No. 319 Declaration of Elaine Herrmann Blais - Public Redacted Version of ECF No. 321 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 432 | Memorandum in Support of Motion (18) Docket Text: MEMORANDUM in Support re [431] MOTION to Exclude Certain Opinions of Defendant's Expert James McDonnell, PH.D. - Public Redacted Version of ECF No. 322 - Public Redacted Version of ECF No. 323 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 435 | Memorandum in Support of Motion (27) Docket Text: MEMORANDUM in Support re [434] MOTION to Exclude Certain Opinions of Defendant's Expert Dr. Andrew Charles - Public Redacted Version of ECF No. 325 - Public Redacted Version of ECF No. 326 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 437 | Opposition to Motion (30) Docket Text: Opposition re [293] MOTION for Summary Judgment Invalidity for Lack of Written Description - Public Redacted Version of ECF No. 347 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 438 | Response (30) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [295] Statement of Material Facts L.R. 56.1, L.R. 56.1 Responsive Statement of Material Facts in Support of Plaintiffs' Opposition to Defendant's Motion for Summary Judgment for Lack of Written Description - Public Redacted Version of ECF No. 351. (Blais, Elaine) |
| Jul 27, 2022 | 439 | Opposition to Motion (30) Docket Text: Opposition re [289] MOTION for Summary Judgment Invalidity for Lack of Enablement - Public Redacted Version of ECF No. 353 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 440 | Response (30) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [291] Statement of Material Facts L.R. 56.1, L.R. 56.1 Responsive Statement of Material Facts in Support of Plaintiffs' Opposition to Defendant's Motion for Summary Judgment for Lack of Enablement - Public Redacted Version of ECF No. 355. (Blais, Elaine) |
| Jul 27, 2022 | 441 | Declaration (7) Docket Text: DECLARATION re [437] Opposition to Motion, [439] Opposition to Motion Declaration of Yasmina Abdiche, Ph.D. in Support of Teva's Oppositions to Lilly's Motions for Summary Judgment of Invalidity for (1) Lack of Enablement, and (2) Lack of Written Description - Public Redacted Version of ECF No. 357 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 442 | Opposition to Motion (27) Docket Text: Opposition re [297] MOTION for Partial Summary Judgment Non Infringement Doctrine of Equivalents - Public Redacted Version of ECF No. 360 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 443 | Response (30) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [299] Statement of Material Facts L.R. 56.1, L.R. 56.1 Responsive Statement of Material Facts in Support of Plaintiffs' Opposition to Defendant's Motion for Partial Summary Judgment on Non-Infringement - Public Redacted Version of ECF No. 362. (Blais, Elaine) |
| Jul 27, 2022 | 444 | Response (30) Docket Text: Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [307] Statement of Material Facts L.R. 56.1, L.R. 56.1 Responsive Statement of Material Facts in Support of Plaintiffs' Opposition to Defendant's Motion for Partial Summary Judgment of No Willful Infringement - Public Redacted Version of ECF No. 366. (Blais, Elaine) |
| Jul 27, 2022 | 445 | Opposition to Motion (22) Docket Text: Opposition re [310] MOTION TO PARTIALLY EXCLUDE TESTIMONY OF DR. ELAN RUBINSTEIN AND DR. MARK BERKMAN - Public Redacted Version of ECF No. 372 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 27, 2022 | 446 | Opposition to Motion (23) Docket Text: Opposition re [305] MOTION for Partial Summary Judgment No Willful Infringement - Public Redacted Version of ECF No. 373 filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 26, 2022 | 416 | Letter/request (non-motion) (1) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais Requesting Clarification on Trial Schedule. (Blais, Elaine) |
| Jun 6, 2022 | 382 | Motion to Seal (8) Docket Text: Assented to MOTION to Seal re Summary Judgment and Daubert Reply Memoranda and Exhibits by Eli Lilly and Company.(Martin, Andrea) |
| Jun 6, 2022 | 383 | Motion to Seal (4) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' Replies in Support of Teva's Motions for Summary Judgment and Daubert Motions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Jun 6, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [382] Motion to Seal. (Folan, Karen) |
| Jun 6, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [383] Motion to Seal. (Folan, Karen) |
| Jun 2, 2022 | 380 | Stipulation (30) Docket Text: STIPULATION re [58] Protective Order [Proposed] Joint Stipulated Protective Order by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jun 2, 2022 | 381 | Order (30) Docket Text: Judge Allison D. Burroughs: ORDER entered APPROVING [380] Stipulation for Protective Order filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| May 16, 2022 | 375 | Declaration (3) Docket Text: DECLARATION re [353] Opposition to Motion, [360] Opposition to Motion, [373] Opposition to Motion, [347] Opposition to Motion, [364] Opposition to Motion, Expert Declaration of Dr. Andrew Blumenfeld in Support of Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc.'s Oppositions to Lilly's Motions for Summary Judgment by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 16, 2022 | 376 | Declaration (3) Docket Text: DECLARATION re [353] Opposition to Motion, [360] Opposition to Motion, [373] Opposition to Motion, [347] Opposition to Motion, [364] Opposition to Motion, Expert Declaration of Geoffrey Hale, PH.D., in Support of Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc.'s Oppositions to Lilly's Motions for Summary Judgment by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 16, 2022 | 377 | Declaration (3) Docket Text: DECLARATION re [353] Opposition to Motion, [360] Opposition to Motion, [373] Opposition to Motion, [347] Opposition to Motion, [364] Opposition to Motion, Expert Declaration of Dr. Jeffrey Ravetech in Support of Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc.'s Oppositions to Lilly's Motions for Summary Judgment by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 16, 2022 | 378 | Declaration (3) Docket Text: DECLARATION re [353] Opposition to Motion, [360] Opposition to Motion, [373] Opposition to Motion, [347] Opposition to Motion, [364] Opposition to Motion, Expert Declaration of Mark P. Berkman, PH.D., in Support of Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc.'s Oppositions to Lilly's Motions for Summary Judgment by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 16, 2022 | 379 | Declaration (3) Docket Text: DECLARATION re [353] Opposition to Motion, [360] Opposition to Motion, [373] Opposition to Motion, [347] Opposition to Motion, [364] Opposition to Motion, Expert Declaration of Dr. Pamela Blake in Support of Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc.'s Oppositions to Lilly's Motions for Summary Judgment by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 13, 2022 | 374 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Tara Rose Thigpen on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Thigpen, Tara) |
| May 10, 2022 | 346 | Declaration (5) Docket Text: DECLARATION re [344] Opposition to Motion Declaration of Mark P. Berkman in Support of Plaintiffs' Opposition to Defendant Eli Lilly and Company's Daubert Motion to Partially Exclude Testimony of Dr. Elan Rubinstein and Dr. Mark Berkman by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 6, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [338] Motion to Seal Confidential Portions of Plaintiffs' Oppositions to Defendant Eli Lilly's Motions for Summary Judgment and Daubert Motions.(Folan, Karen) |
| May 6, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [339] Motion to Seal Or Otherwise Impound Confidential Portions of Defendant's Opposition Memoranda And Certain Exhibits. (Folan, Karen) |
| May 6, 2022 | 342 | Motion for Extension of Time (4) Docket Text: Assented to MOTION for Extension of Time to file Opposition and Reply Briefs in Support of Motion for Summary Judgment and Daubert Motions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| May 6, 2022 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [342] Motion for Extension of Time to file Opposition and Reply Briefs in Support of Motion for Summary Judgment and Daubert Motions. (Folan, Karen) |
| May 5, 2022 | 338 | Motion to Seal (5) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' Oppositions to Defendant Eli Lilly's Motions for Summary Judgment and Daubert Motions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| May 5, 2022 | 339 | Motion to Seal (13) Docket Text: Assented to MOTION to Seal Or Otherwise Impound Confidential Portions of Defendant's Opposition Memoranda And Certain Exhibits by Eli Lilly and Company.(Martin, Andrea) |
| May 2, 2022 | 332 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Madeline R. DiLascia and Sean M. Anderson Filing fee: $ 200, receipt number AMADC-9301387 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| May 2, 2022 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [332] Motion for Leave to Appear Pro Hac Vice Added Madeline R. DiLascia and Sean M. Anderson. Attorneys admitted Pro Hac Vice must have an individual PACER account, not a shared firm account, to electronically file in the District of Massachusetts. To register for a PACER account, go the Pacer website at https://pacer.uscourts.gov/register-account.Pro Hac Vice Admission Request Instructions https://www.mad.uscourts.gov/caseinfo/nextgen-pro-hac-vice.htm.A Notice of Appearance must be entered on the docket by the newly admitted attorney. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McManus, Caetlin) |
| May 2, 2022 | 335 | Answer to Complaint (30) Docket Text: SECOND AMENDED ANSWER to Complaint with Jury Demand , COUNTERCLAIM REDACTED to replace Dkt 263 against Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. by Eli Lilly and Company.(Martin, Andrea) |
| May 2, 2022 | 337 | Answer to Complaint (30) Docket Text: SUPPLEMENTAL SECOND AMENDED ANSWER to [1] Complaint,,, with Jury Demand , COUNTERCLAIM REDACTED to replace Dkt 277 against Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. by Eli Lilly and Company.(Martin, Andrea) |
| Apr 27, 2022 | 330 | Motion for Extension of Time (3) Docket Text: Assented to MOTION for Extension of Time to file Opposition and Reply Briefs in Support of Motion for Summary Judgment and Daubert Motions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Daughtrey, Natasha) |
| Apr 27, 2022 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [330] Motion for Extension of Time to file Opposition and Reply Briefs in Support of Motion for Summary Judgment and Daubert Motions. (Folan, Karen) |
| Apr 18, 2022 | 329 | Redacted Document (30) Docket Text: REDACTION to[279] Answer to Counterclaim, byTeva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Apr 12, 2022 | 328 | Stipulation (2) Docket Text: STIPULATION Regarding Knowledge of Patents-In-Suit by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Mar 28, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [284] Motion to Seal. (Folan, Karen) |
| Mar 28, 2022 | 286 | Stipulation (5) Docket Text: STIPULATION (Joint) and [PROPOSED] Order Regarding Asserted Claims by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Mar 28, 2022 | 287 | Order (5) Docket Text: Judge Allison D. Burroughs: ORDER entered APPROVING [286] Stipulation filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| Mar 28, 2022 | 288 | Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance by Shaobo Zhu (Zhu, Shaobo) |
| Mar 28, 2022 | 289 | Motion for Summary Judgment (3) Docket Text: MOTION for Summary Judgment Invalidity for Lack of Enablement by Eli Lilly and Company.(Martin, Andrea) |
| Mar 28, 2022 | 293 | Motion for Summary Judgment (3) Docket Text: MOTION for Summary Judgment Invalidity for Lack of Written Description by Eli Lilly and Company.(Martin, Andrea) |
| Mar 28, 2022 | 297 | Motion for Partial Summary Judgment (3) Docket Text: MOTION for Partial Summary Judgment Non Infringement Doctrine of Equivalents by Eli Lilly and Company.(Martin, Andrea) |
| Mar 28, 2022 | 305 | Motion for Partial Summary Judgment (3) Docket Text: MOTION for Partial Summary Judgment No Willful Infringement by Eli Lilly and Company.(Martin, Andrea) |
| Mar 28, 2022 | 310 | Motion for Miscellaneous Relief (3) Docket Text: MOTION TO PARTIALLY EXCLUDE TESTIMONY OF DR. ELAN RUBINSTEIN AND DR. MARK BERKMAN by Eli Lilly and Company.(Martin, Andrea) |
| Mar 28, 2022 | 318 | Notice (Other) (4) Docket Text: NOTICE by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. Notice of Filing of Plaintiff's Motion for Summary Judgment, Motion to Exclude Expert Testimony, and Supporting Documents (Blais, Elaine) |
| Mar 27, 2022 | 284 | Motion to Seal (21) Docket Text: Assented to MOTION to Seal Portions of Defendant's Memoranda and Certain Exhibits by Eli Lilly and Company.(Martin, Andrea) |
| Mar 24, 2022 | 282 | Motion for Extension of Time (3) Docket Text: Assented to MOTION for Extension of Time to 2 Business Days to Extend Briefing Deadlines for Summary Judgment and Daubert Motions by Eli Lilly and Company.(Martin, Andrea) |
| Mar 24, 2022 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [282] Motion for Extension of Time to 2 Business Days to Extend Briefing Deadlines for Summary Judgment and Daubert Motions. (Folan, Karen) |
| Mar 23, 2022 | 280 | Motion to Seal (9) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' Motions for Summary Judgment and Daubert Motions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Mar 23, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [280] Motion to Seal. (Folan, Karen) |
| Mar 2, 2022 | 276 | Motion to Seal (4) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' Answer to Defendant's Supplemental Second Amended Answer and Affirmative Defenses by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Mar 2, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [276] Motion to Seal. (Folan, Karen) |
| Feb 24, 2022 | N/A | Order on Motion to Amend (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [273] Motion to Amend. (Folan, Karen) |
| Feb 22, 2022 | N/A | Order on Motion for Leave to File Excess Pages (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [270] Motion for Leave to File Excess Pages ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Feb 18, 2022 | 271 | Notice of Withdrawal of Appearance (3) Docket Text: NOTICE of Withdrawal of Appearance by Andrea L. Martin Withdrawal of Daniel F. Roland (Martin, Andrea) |
| Feb 16, 2022 | 268 | Motion for Extension of Time (3) Docket Text: Second MOTION for Extension of Time to February 23, 2022 to File Answer to Defendant's Second Amended Counterclaims (Unopposed) by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Feb 16, 2022 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [268] Motion for Extension of Time to February 23, 2022 to File Answer to Defendant's Second Amended Counterclaims. (Folan, Karen) |
| Feb 11, 2022 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [264] Motion to Extend Summary Judgment and Daubert Deadlines. (Folan, Karen) |
| Feb 11, 2022 | 266 | Motion for Extension of Time (3) Docket Text: MOTION for Extension of Time to February 16, 2022 to File Plaintiffs' Answer to Defendant's Second Amended Counterclaims (Unopposed) by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Feb 11, 2022 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [266] Motion for Extension of Time to February 16, 2022 to File Plaintiffs' Answer to Defendant's Second Amended Counterclaims. (Folan, Karen) |
| Feb 10, 2022 | 264 | Motion for Extension of Time (5) Docket Text: Joint MOTION for Extension of Time to Extend Summary Judgment and Daubert Deadlines by Eli Lilly and Company.(Martin, Andrea) |
| Feb 3, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [260] Motion to Seal. (Folan, Karen) |
| Feb 2, 2022 | 260 | Motion to Seal (8) Docket Text: Assented to MOTION to Seal Confidential Second Amended Answer and Counterclaims and Exhibits by Eli Lilly and Company.(Martin, Andrea) |
| Jan 26, 2022 | 258 | Transcript (22) Docket Text: Transcript of Status Conference held on January 20, 2022, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Joan Daly at joanmdaly62@gmail.com. Redaction Request due 2/16/2022. Redacted Transcript Deadline set for 2/28/2022. Release of Transcript Restriction set for 4/26/2022. (Coppola, Katelyn) |
| Jan 26, 2022 | N/A | Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Coppola, Katelyn) |
| Jan 25, 2022 | N/A | Notice of Hearing (0) Docket Text: ELECTRONIC NOTICE of Hearing. Jury Trial set for 10/18/2022 09:00 AM in Courtroom 17 before Judge Allison D. Burroughs. (Folan, Karen) |
| Jan 25, 2022 | 257 | Procedural Order re pretrial/trial (3) Docket Text: Judge Allison D. Burroughs: ORDER entered. PROCEDURAL ORDER re pretrial/trial. Motions in limine shall be filed no later than September 16, 2022. Oppositions to motions in limine shall be filed by September 29, 2022. Final Pretrial Conference set for 10/6/2022 09:30 AM in Courtroom 17 (In person only) before Judge Allison D. Burroughs. Jury Trial set for 10/18/2022 09:00 AM in Courtroom 17 before Judge Allison D. Burroughs. (McManus, Caetlin) |
| Jan 20, 2022 | N/A | Status Conference (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Status Conference held on 1/20/2022. Oral motion to file new answer granted. Amended answer to be filed. Colloquy re: trial. Trial estimated to be 3 weeks. Parties to confer regarding a trial date in the fall and will get back to court. (Court Reporter: Joan Daly at joanmdaly62@gmail.com.) (Folan, Karen) |
| Jan 12, 2022 | 253 | Motion for Extension of Time to File Answer (6) Docket Text: Joint MOTION for Extension of Time to File Answer re [238] Answer to Complaint,,,,,,,,,,, Counterclaim,,,,,,,,,, by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Jan 12, 2022 | N/A | Order on Motion for Extension of Time to Answer (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [253] Motion for Extension of Time to Answer to amended counterclaims. (Folan, Karen) |
| Jan 11, 2022 | 251 | Memorandum & ORDER (26) Docket Text: Judge Allison D. Burroughs: REDACTED MEMORANDUM AND ORDER entered. Teva's motion for sanctions, [ECF No. [143]], is DENIED, Lilly's motion to exclude, [ECF No. [181]], is DENIED, and Lilly's motion to amend, [ECF No. [175]], is GRANTED. SO ORDERED. (McManus, Caetlin) |
| Jan 11, 2022 | N/A | Notice of Hearing (0) Docket Text: ELECTRONIC NOTICE of Hearing. Status Conference regarding ECF Nos. 241, 243, and 247 set for 1/20/2022 01:00 PM in Remote Proceeding : Boston before Judge Allison D. Burroughs. (Folan, Karen) |
| Jan 10, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [246] Assented to MOTION to Seal Letter to Court. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Jan 7, 2022 | N/A | Order on Motion to Amend (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [245] Motion to Amend case schedule. (Folan, Karen) |
| Jan 6, 2022 | 245 | Motion to Amend (5) Docket Text: Joint MOTION to Amend Case Schedule by Eli Lilly and Company.(Martin, Andrea) |
| Jan 6, 2022 | 246 | Motion to Seal (2) Docket Text: Assented to MOTION to Seal Letter to Court by Eli Lilly and Company.(Martin, Andrea) |
| Jan 5, 2022 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [242] Assented to MOTION to Seal Confidential Portions of Plaintiffs' January 4, 2022 Letter to the Honorable Allison D. Burroughs and Exhibits. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Jan 4, 2022 | 241 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Eli Lilly requesting Tele Conf re Court 12.20 Order on Amended Answer. (Martin, Andrea) |
| Jan 4, 2022 | 242 | Motion to Seal (4) Docket Text: Assented to MOTION to Seal Confidential Portions of Plaintiffs' January 4, 2022 Letter to the Honorable Allison D. Burroughs and Exhibits by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Dec 30, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [239] Assented to MOTION to Seal Amended Answer Counterclaim and Exhibits. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Dec 29, 2021 | 239 | Motion to Seal (7) Docket Text: Assented to MOTION to Seal Amended Answer Counterclaim and Exhibits by Eli Lilly and Company.(Martin, Andrea) |
| Dec 20, 2021 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. The Court has filed its Memorandum and Order on Teva's motion for sanctions and Lilly's motions to exclude and amend under seal because it contains references to materials that have been filed under seal. The parties shall confer and, no later than January 11, 2022, propose any redactions to the Court so that an unredacted or partially redacted version of the Order may be placed on the public docket. (McDonagh, Christina) |
| Dec 1, 2021 | 235 | Letter/request (non-motion) (1) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais regarding ECF No. 181. (Blais, Elaine) |
| Nov 18, 2021 | 231 | Sur-Reply to Motion (10) Docket Text: SUR-REPLY to Motion re [175] MOTION for Leave to File Amended Answer (Redacted Version) filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Nov 18, 2021 | 233 | Reply to Response to Motion (17) Docket Text: REPLY to Response to [175] MOTION for Leave to File Amended Answer Redacted replaces Dkt 221 filed by Eli Lilly and Company. (Martin, Andrea) |
| Nov 15, 2021 | 227 | Motion for Leave to File (4) Docket Text: Assented to MOTION for Leave to File Confidential Portions of Plaintiffs' Surreply Under Seal in Opposition to Motion for Leave to Amend Answer and Exhibits by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Nov 15, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [227] Motion for Leave to File Document under seal. (Folan, Karen) |
| Nov 10, 2021 | 225 | Reply to Response to Motion (14) Docket Text: REPLY to Response to [181] MOTION to Strike Exclude Dr Hale As Expert And Preclude Disclosure of Protected Information Redacted Replaces Dkt 208 filed by Eli Lilly and Company. (Martin, Andrea) |
| Nov 8, 2021 | 223 | Motion for Leave to File (3) Docket Text: Assented to MOTION for Leave to File Sur-reply Memorandum in Response to Eli Lilly and Company's Motion for Leave to Amend Answer by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Nov 8, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [223] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Nov 4, 2021 | 219 | Motion for Leave to File (4) Docket Text: Assented to MOTION for Leave to File Reply and Exhibits Under Seal re Motion to Amend Answer by Eli Lilly and Company.(Martin, Andrea) |
| Nov 4, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [219] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Nov 2, 2021 | 217 | Opposition to Motion (25) Docket Text: Opposition re [175] MOTION for Leave to File Amended Answer Redacted Version filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Nov 1, 2021 | 216 | Stipulation (6) Docket Text: STIPULATION [Joint] and Proposed Order re Authentication of Documents by Eli Lilly and Company. (Martin, Andrea) |
| Oct 29, 2021 | 214 | Motion for Extension of Time (3) Docket Text: Assented to MOTION for Extension of Time to 11/01/2021 to Respond to Opening Expert Reports by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 29, 2021 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [214] Motion for Extension of Time to 11/01/2021 to Respond to Opening Expert Reports. (Folan, Karen) |
| Oct 28, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [212] Assented to MOTION for Leave to File to File Reply in support of Motion to Amend Answer ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Oct 27, 2021 | 212 | Motion for Leave to File (3) Docket Text: Assented to MOTION for Leave to File to File Reply in support of Motion to Amend Answer by Eli Lilly and Company.(Martin, Andrea) |
| Oct 26, 2021 | 211 | Letter/request (non-motion) (1) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais regarding Defendant Eli Lilly and Company's Motion to Exclude Dr. Geoffrey Hale as an Expert Witness (ECF No. 181). (Blais, Elaine) |
| Oct 25, 2021 | 203 | Motion for Leave to File (4) Docket Text: MOTION for Leave to File Impounded Confidential Portions of Plaintiffs' Opposition to Motion for Leave to Amend Answer and Exhibits by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 25, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [203] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Oct 25, 2021 | 205 | Motion to Seal (4) Docket Text: MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Defendant's Reply in support of Motion to Exclude Dr. Hale by Eli Lilly and Company.(Martin, Andrea) |
| Oct 25, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [205] Motion to Seal. (Folan, Karen) |
| Oct 22, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [195] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Oct 22, 2021 | 200 | Opposition to Motion (25) Docket Text: Opposition re [181] MOTION to Strike Exclude Dr Hale As Expert And Preclude Disclosure of Protected Information Redacted Version filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 22, 2021 | 202 | Declaration (4) Docket Text: DECLARATION re [200] Opposition to Motion, of Dr. Geoffrey Hale in Support of Plaintiffs Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc.'s Opposition to Motion to Exclude Dr. Geoffrey Hale as an Expert, Redacted Version by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 20, 2021 | 195 | Motion for Leave to File (3) Docket Text: Assented to MOTION for Leave to File Reply in support of Motion to Exclude Hale (Dkt 181) by Eli Lilly and Company.(Martin, Andrea) |
| Oct 20, 2021 | 196 | Memorandum in Support of Motion (21) Docket Text: MEMORANDUM in Support re [181] MOTION to Strike Exclude Dr Hale As Expert And Preclude Disclosure of Protected Information Redacted replace Dkt 182 filed by Eli Lilly and Company. (Martin, Andrea) |
| Oct 19, 2021 | 188 | Motion to Seal (4) Docket Text: MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Plaintiffs' Opposition to Motion to Exclude Dr. Geoffrey Hale as an Expert and Exhibits by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 19, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [188] Motion to Seal. (Folan, Karen) |
| Oct 13, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [180] Motion to Seal. (Folan, Karen) |
| Oct 13, 2021 | 186 | Motion for Extension of Time to File Response/Reply (3) Docket Text: Assented to MOTION for Extension of Time to October 25, 2021 to File Response/Reply as to [175] MOTION for Leave to File Amended Answer by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 13, 2021 | N/A | Order on Motion for Extension of Time to File Response/Reply (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [186] Motion for Extension of Time to File Response/Reply to October 25, 2021 to File Response/Reply as to [175] MOTION for Leave to File Amended Answer , [175] MOTION for Leave to File Amended Answer Responses due by 10/25/2021 (Folan, Karen) |
| Oct 12, 2021 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [178] Motion for Extension of Time for case schedule. (Folan, Karen) |
| Oct 12, 2021 | 180 | Motion to Seal (6) Docket Text: MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Defendant's Motion to Exclude Dr. Hale by Eli Lilly and Company.(Martin, Andrea) |
| Oct 12, 2021 | 181 | Motion to Strike (4) Docket Text: MOTION to Strike Exclude Dr Hale As Expert And Preclude Disclosure of Protected Information by Eli Lilly and Company.(Martin, Andrea) |
| Oct 11, 2021 | 178 | Motion for Extension of Time (6) Docket Text: Joint MOTION for Extension of Time to Case Schedule by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Oct 4, 2021 | 173 | Motion to Seal (4) Docket Text: Assented to MOTION to Seal Confidential Exhibits to Motion for Leave to Amend Answer by Eli Lilly and Company.(Martin, Andrea) |
| Oct 4, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [173] Motion to Seal. (Folan, Karen) |
| Oct 4, 2021 | 175 | Motion for Leave to File (3) Docket Text: MOTION for Leave to File Amended Answer by Eli Lilly and Company.(Martin, Andrea) |
| Sep 23, 2021 | 167 | Motion to Seal (3) Docket Text: MOTION to Seal Unopposed Motion for Leave to Impound Sur-Reply re: Motion for Sanctions by Eli Lilly and Company.(Martin, Andrea) |
| Sep 23, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [167] Motion to Seal. (Folan, Karen) |
| Sep 23, 2021 | 169 | Reply to Response to Motion (15) Docket Text: REPLY to Response to [143] MOTION for Sanctions Pursuant to Fed R. Civ. P. 37(B) Redacted Public Version filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Sep 18, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [165] MOTION for Leave to File Unopposed Motion for Leave to File Sur-Reply re: Motion for Sanctions ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Sep 17, 2021 | 165 | Motion for Leave to File (3) Docket Text: MOTION for Leave to File Unopposed Motion for Leave to File Sur-Reply re: Motion for Sanctions by Eli Lilly and Company.(Martin, Andrea) |
| Sep 16, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [159] Motion to Seal. (Folan, Karen) |
| Sep 16, 2021 | 164 | Order (7) Docket Text: Judge Allison D. Burroughs: ORDER entered APPROVING [160] Stipulation filed by Eli Lilly and Company.(Folan, Karen) |
| Sep 15, 2021 | 159 | Motion to Seal (4) Docket Text: MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Plaintiffs' Reply Memorandum in Support of Motion for Sanctions Pursuant to Fed. R. Civ. P. 37(B) and Exhibits by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Daughtrey, Natasha) |
| Sep 15, 2021 | 160 | Stipulation (7) Docket Text: STIPULATION JOINT STIPULATION AND [PROPOSED] ORDER OF DISMISSAL OF CERTAIN CLAIMS AND DEFENSES by Eli Lilly and Company. (Martin, Andrea) |
| Sep 10, 2021 | 157 | Opposition to Motion (26) Docket Text: Opposition re [143] MOTION for Sanctions Pursuant to Fed R. Civ. P. 37(B) REDACTED Leave to File Under Seal Granted 9/2/21 filed by Eli Lilly and Company. (Martin, Andrea) |
| Sep 7, 2021 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [155] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Sep 3, 2021 | 155 | Motion for Leave to File (4) Docket Text: MOTION for Leave to File Reply Memorandum of Law in Support of Plaintiffs' Motion for Sanctions Pursuant to Fed. R. Civ. P. 37(B) by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Daughtrey, Natasha) |
| Sep 2, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [150] MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Defendant's Opposition to Motion for Sanctions and Exhibits. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Sep 2, 2021 | 154 | Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance by Andrea L. Martin of attorney Amana Abdulwakeel (Martin, Andrea) |
| Sep 1, 2021 | 150 | Motion to Seal (5) Docket Text: MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Defendant's Opposition to Motion for Sanctions and Exhibits by Eli Lilly and Company.(Martin, Andrea) |
| Aug 26, 2021 | 149 | Memorandum in Support of Motion (25) Docket Text: MEMORANDUM in Support re [143] MOTION for Sanctions Pursuant to Fed R. Civ. P. 37(B) Redacted Public Version filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Aug 23, 2021 | 148 | Letter/request (non-motion) (1) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais regarding Dkt Nos. 137, 138. (Blais, Elaine) |
| Aug 20, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [142] MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Plaintiffs' Motion for Sanctions Pursuant to Fed R. Civ. P. 37(B) and Exhibits. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Aug 18, 2021 | 142 | Motion to Seal (5) Docket Text: MOTION to Seal Uncontested Motion for Leave to Impound Confidential Portions of Plaintiffs' Motion for Sanctions Pursuant to Fed R. Civ. P. 37(B) and Exhibits by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Aug 18, 2021 | 143 | Motion for Sanctions (3) Docket Text: MOTION for Sanctions Pursuant to Fed R. Civ. P. 37(B) by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Aug 18, 2021 | 146 | Letter/request (non-motion) (1) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais Correction to (Dkt 141) Letter from Natasha E. Daughtrey Response to (Dkt 140) Letter from Eli Lilly re Federal Circuit Decisions IPR. (Blais, Elaine) |
| Aug 17, 2021 | 141 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Natasha E. Daughtrey Response to (Dkt 140) Letter from Eli Lilly re Federal Circuit Decisions IPR. (Daughtrey, Natasha) |
| Aug 16, 2021 | 139 | Notice (Other) (2) Docket Text: NOTICE by Eli Lilly and Company re [137] Order, Terminate Motions Re: Prior Art Searches (Martin, Andrea) |
| Aug 9, 2021 | 137 | Order (5) Docket Text: Judge Allison D. Burroughs: ORDER entered. Teva's request, [ECF No. [130]], is GRANTED in part and DENIED in part.(McDonagh, Christina) Modified on 8/24/2021 to unseal document with consent of parties.(McDonagh, Christina). |
| Aug 9, 2021 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. The Court has filed its Order on the parties' discovery dispute under seal because it contains references to materials that have been filed under seal. The parties shall confer and, no later than August 23, 2021, propose any redactions to the Court so that an unredacted or partially redacted version of the Order may be placed on the public docket. (McDonagh, Christina) |
| Jul 21, 2021 | 136 | Letter/request (non-motion) (3) Docket Text: Letter/request (non-motion) from Robert Frederickson III Reply to Response (Dkt 133) to Letter (Dkt 130) regarding request to compel Defendant Eli Lilly and Company to provide corporate testimony regarding Lilly's prior art searches. (Frederickson, Robert) |
| Jul 16, 2021 | 134 | Motion to Seal Document (3) Docket Text: Assented to MOTION to Seal Document [133] Letter/request (non-motion) re Exhibit 4 by Eli Lilly and Company.(Martin, Andrea) |
| Jul 16, 2021 | N/A | Order on Motion to Seal Document (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [134] Assented to MOTION to Seal Document 133 Letter/request (non-motion) re Exhibit 4. (McDonagh, Christina) |
| Jul 8, 2021 | N/A | Order on Motion to Seal Document (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [131] Motion to Seal Document. (Folan, Karen) |
| Jul 7, 2021 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [128] Motion for Extension of Time to August 23, 2021 to Complete Fact Discovery. (Folan, Karen) |
| Jul 7, 2021 | 131 | Motion to Seal Document (3) Docket Text: Assented to MOTION to Seal Document [130] Letter/request (non-motion) (Motion for Leave to Impound Confidential Portions of Plaintiffs' Letter to Court and Exhibits) by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Daughtrey, Natasha) |
| Jul 2, 2021 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [126] Motion for Extension of Time. (Folan, Karen) |
| Jul 2, 2021 | 128 | Motion for Extension of Time (8) Docket Text: Joint MOTION for Extension of Time to August 23, 2021 to Complete Fact Discovery by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Jun 30, 2021 | 126 | Motion for Extension of Time (5) Docket Text: Joint MOTION for Extension of Time to July 2, 2021 to Complete Fact Discovery by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Jun 23, 2021 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [124] Motion for Leave to Appear Pro Hac Vice Added Ryan P. OQuinn. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| May 12, 2021 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [122] Motion for Leave to Appear Pro Hac Vice Added Pier D. DeRoo. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| May 10, 2021 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [117] Motion for Leave to Appear Pro Hac Vice Added Daniel F. Roland, Yoonjin Lee, Amana Abdulwakeel, and Marta Garcia Daneshvar. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| May 10, 2021 | 119 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Oulu Wang on behalf of Eli Lilly and Company (Wang, Oulu) |
| May 10, 2021 | 120 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Kathleen A. McGuiness on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (McGuiness, Kathleen) |
| May 10, 2021 | 121 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Shaobo Zhu on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Zhu, Shaobo) |
| Mar 30, 2021 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. After reviewing the letters submitted by the parties concerning a discovery dispute, [ECF Nos. [102], [110], [111]], the Court agrees that, in this litigation, relevance does not necessarily turn on whether a document was created before Teva's complaint was filed. Therefore, documents created after September 27, 2018 may be relevant to the claims and defenses in this litigation, and those relevant document should be produced despite the relative burden the review and production of those documents may impose on Teva. Accordingly, to the extent that Teva has not already done so, it is ordered to review post-complaint documents captured by the parties' agreed upon search terms and to produce all relevant, responsive documents created between September 27, 2018 and the date of this Order, insofar as such documents are not protected by attorney-client or any other relevant privilege. (McDonagh, Christina) |
| Mar 29, 2021 | 115 | Stipulation (11) Docket Text: STIPULATION re: Protocol for Remote Depositions by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Mar 26, 2021 | N/A | Order on Motion for Extension of Time to Complete Discovery (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [113] Motion for Extension of Time to Complete Discovery and amend scheduling order deadlines. (Folan, Karen) |
| Mar 25, 2021 | N/A | Order on Motion for Extension of Time to Complete Discovery (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered denying [107] Motion for Extension of Time to Complete Discovery. Denied with leave to renew. (Folan, Karen) |
| Mar 25, 2021 | 113 | Motion for Extension of Time to Complete Discovery (7) Docket Text: Joint MOTION for Extension of Time to June 30, 2021 to Complete Discovery And Amend Scheduling Order Deadlines by Eli Lilly and Company.(Martin, Andrea) |
| Mar 16, 2021 | 111 | Letter/request (non-motion) (3) Docket Text: Letter/request (non-motion) from Eli Lilly response to Dkt 102 re Date Cutoff . (Martin, Andrea) |
| Mar 10, 2021 | 105 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Denise Main Filing fee: $ 100, receipt number 0101-8673763 by Eli Lilly and Company.(Martin, Andrea) |
| Mar 10, 2021 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [105] Motion for Leave to Appear Pro Hac Vice Added Denise Main. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| Mar 10, 2021 | 107 | Motion for Extension of Time to Complete Discovery (12) Docket Text: MOTION for Extension of Time to June 30, 2021 to Complete Discovery by Eli Lilly and Company.(Martin, Andrea) |
| Mar 8, 2021 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. The parties have submitted several discovery disputes for the Court's consideration via letter/requests. As to Lilly's letter/request regarding Teva's response to Interrogatory No. 1, [ECF No. [93]], Teva is ordered to provide conception and reduction to practice dates for the asserted claims. The Court will not address Lilly's contentions regarding Teva's response to Interrogatory No. 16, as the parties have indicated that the issue is, for the present, moot. [ECF Nos. [96], [97]]. Next, Lilly is ordered to perform a search using the phrase "galca," as described in Teva's letter/request. [ECF No. [99]]. As Teva notes, this is not a product name (Emgality) but is the name of the active ingredient antibody in that product and is therefore highly relevant to this litigation despite the relative burden that running the search may impose on Lilly. As to the second search string that Teva discussed in its letter/request, Lilly represents that it has already agreed to run it, so that issue is moot. [ECF No. [103] at 1]. Lilly has raised an additional discovery dispute regarding cutoff dates. [ECF No. [102]]. The Court will address this dispute once Teva has had an opportunity to respond. In the meantime, if the parties propose extending the current discovery deadline of March 31, 2021, they are advised to request an extension well ahead of the current deadline and to address how that extension may or may not affect subsequent deadlines, including the current December 2021 target date for trial. If necessary, the Court will schedule a status conference once it has a better idea of what the parties are requesting with regards to discovery. (McDonagh, Christina) |
| Feb 24, 2021 | 101 | Memorandum & ORDER (33) Docket Text: Judge Allison D. Burroughs: MEMORANDUM AND ORDER entered. The claim terms at issue will be construed for the jury and for all other purposes in this litigation in a manner consistent with the above rulings of the Court. For ease of reference, the Court's constructions are reproduced below in Appendix A. SO ORDERED.(McDonagh, Christina) |
| Feb 19, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [98] MOTION to Seal Unopposed re Dkt 99 and Exhibits B and C. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Feb 18, 2021 | 98 | Motion to Seal (4) Docket Text: MOTION to Seal Unopposed re Dkt 99 and Exhibits B and C by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Feb 11, 2021 | 96 | Response (4) Docket Text: Letter Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [93] Letter/request (non-motion),, . (Blais, Elaine) |
| Feb 4, 2021 | N/A | Order on Motion to Seal (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [94] Motion to Seal. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Feb 3, 2021 | 94 | Motion to Seal (3) Docket Text: MOTION to Seal UNOBJECTED-TO re Dkt 93 and Exs by Eli Lilly and Company.(Martin, Andrea) |
| Jan 21, 2021 | 90 | Response (8) Docket Text: Plaintiffs' Supplemental Claim Construction Submission Response by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to [89] Notice of Supplemental Authorities, . (Blais, Elaine) |
| Jan 20, 2021 | 91 | Transcript (152) Docket Text: Transcript of Markman Hearing held on December 15, 2020, before Judge Allison D. Burroughs. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Joan Daly at joanmdaly62@gmail.com. Redaction Request due 2/10/2021. Redacted Transcript Deadline set for 2/22/2021. Release of Transcript Restriction set for 4/20/2021. (Coppola, Katelyn) |
| Jan 20, 2021 | N/A | Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Coppola, Katelyn) |
| Jan 8, 2021 | 89 | Notice of Supplemental Authorities (8) Docket Text: Notice of Supplemental Authorities re [63] Joint MOTION for Extension of Time to Extend Claim Construction Briefing ScheduleJoint MOTION for Leave to File Excess Pages Opening Claim Construction Briefs [SUPPLEMENTAL CLAIM CONSTRUCTION BRIEF filed by Eli Lilly and Company. (Martin, Andrea) |
| Dec 15, 2020 | N/A | Markman Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Allison D. Burroughs: Markman Hearing held on 12/15/2020. (Court Reporter: Joan Daly at joanmdaly62@gmail.com.) (Folan, Karen) |
| Dec 10, 2020 | N/A | Notice of Rescheduling (0) Docket Text: ELECTRONIC NOTICE OF RESCHEDULING. NOTICE IS FOR TIME CHANGE ONLY. This hearing will be conducted by video conference. Counsel of record will receive a video conference invite at the email registered in CM/ECF. If you have technical or compatibility issues with the technology, please notify the session's courtroom deputy as soon as possible.Access to the hearing will be made available to the media and public. In order to gain access to the hearing, you must sign up at the following address: https://forms.mad.uscourts.gov/courtlist.html. For questions regarding access to hearings, you may refer to the Court's general orders and public notices available on www.mad.uscourts.gov or contact media@mad.uscourts.gov. Markman Hearing set for 12/15/2020 09:00 AM in Remote Proceeding : Boston before Judge Allison D. Burroughs. (Folan, Karen) |
| Dec 10, 2020 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [85] Motion for Leave to Appear Pro Hac Vice Added Matthew J. Luneack. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| Nov 25, 2020 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. The parties have requested additional information regarding the Markman hearing scheduled for December 15, 2020. [ECF No. [81]]. The Markman hearing will proceed via videoconference; Karen Folan, the Courtroom Clerk, will provide a Zoom link prior to the hearing. The hearing will be limited to 4 hours: arguments will proceed term by term, with Lilly presenting first on each term, and each side will have 20 minutes per term (6 terms total). Terms 3 and 5 should be argued sequentially. As to argument on indefiniteness, the Court will hear argument on the issue but may reserve ruling on it if Lilly is unable to meet its burden. Lastly, the parties' proposal regarding their respective tech tutorials is accepted. (McDonagh, Christina) |
| Nov 24, 2020 | 81 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Both Parties re Markman Hearing. (Martin, Andrea) |
| Oct 23, 2020 | 77 | Reply to Preliminary Claim Construction Briefs (27) Docket Text: Reply to Preliminary Claim Construction Briefs by Eli Lilly and Company. (Martin, Andrea) |
| Oct 23, 2020 | 79 | Reply to Preliminary Claim Construction Briefs (26) Docket Text: Reply to Preliminary Claim Construction Briefs by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Oct 1, 2020 | 76 | Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance by Martin C. Topol (Topol, Martin) |
| Sep 29, 2020 | 75 | Stipulation (9) Docket Text: STIPULATION re Protocol for Remote Depositions Relating to Claim Construction by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Frederickson, Robert) |
| Sep 25, 2020 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. The Court has reviewed the parties' letter/request and response regarding Lilly's purportedly new assertion of an invalidity defense. [ECF Nos. [71] and [72]]. As the Court made clear when staying the case for IPR, Lilly will not be permitted "to relitigate any invalidity arguments that are or could be addressed in the IPRs." [ECF No. [43] at 14 n.14]. Lilly claims that it was not aware of the prior art reference at issue and therefore could not have raised it with its invalidity arguments in the IPRs. [ECF No. [72] at 1]. Teva suggests the parties brief the issue through a motion to strike, [ECF No. [71] at 2 n.3], while Lilly contends that the issue is best dealt with at summary judgment, [ECF No. [72] at 2]."It appears that the issue of whether a skilled, diligent search reasonably should have uncovered a reference is a question of fact" appropriate for resolution at summary judgment. SiOnyx, LLC v. Hamamatsu Photonics K.K., 330 F. Supp. 3d 574, 601 (D. Mass. 2018). The Court is inclined to review the issue using the framework set forth in Palomar Techs., Inc. v. MRSI Sys., LLC, No. 18-cv-10236, 2020 U.S. Dist. LEXIS 77929, at *12-13 (D. Mass. May 4, 2020) (setting out burden-shifting framework). Accordingly, if Teva pursues the 35 U.S.C. § 315(e)(2) estoppel bar as to Lilly's purportedly new invalidity argument at summary judgment, Teva will need to make a prima facie showing that the bar applies by demonstrating that Lilly "raised or reasonably could have raised" the contested reference in the IPRs. 35 U.S.C. § 315(e)(2); Palomar, 2020 U.S. Dist. LEXIS 77929, at *12. Lilly, if it chooses to contest the issue, will then "have the burden of proving both (1) that it did not actually know about the references and (2) that a skilled searcher conducting a diligent search reasonably could not have been expected to discover the references." Palomar, 2020 U.S. Dist. LEXIS 77929, at *13. Recognizing that the issue of burden with regard to estoppel and invalidity could be viewed as unsettled, the parties may brief this issue at summary judgment if they want to argue that Palomar does not articulate the proper approach.(McDonagh, Christina) |
| Sep 24, 2020 | N/A | Order Lifting Stay (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. On April 22, 2019, this case was stayed pending the resolution of nine petitions for inter partes review ("IPR"). [ECF No. [43]]. On April 8, 2020, the parties indicated that the PTAB had issued decisions on all nine IPRs, and that the parties were prepared to resume litigation in this matter. [ECF No. [44]]. Accordingly, the stay is lifted.(McDonagh, Christina) |
| Sep 17, 2020 | 72 | Letter/request (non-motion) (2) Docket Text: Responsive Letter/request (non-motion) from Andrea L. Martin to the Court Regarding Docket No. 71. (Martin, Andrea) |
| Sep 15, 2020 | 71 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais . (Blais, Elaine) |
| Sep 11, 2020 | 65 | Preliminary Claim Construction Briefs (30) Docket Text: Preliminary Claim Construction Briefs by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Sep 11, 2020 | 66 | Preliminary Claim Construction Briefs (30) Docket Text: Preliminary Claim Construction Briefs by Eli Lilly and Company. (Martin, Andrea) |
| Sep 2, 2020 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [63] Motion to Extend Claim Construction Briefing Schedule and Page Limits. (Folan, Karen) |
| Aug 28, 2020 | 63 | Motion for Extension of Time (4) Docket Text: Joint MOTION for Extension of Time to Extend Claim Construction Briefing Schedule, Joint MOTION for Leave to File Excess Pages Opening Claim Construction Briefs ( Responses due by 9/11/2020) by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Aug 24, 2020 | 61 | Order (7) Docket Text: Judge Allison D. Burroughs: ORDER entered. Joint Stipulated Protocol Governing Privilege Logs. (McDonagh, Christina) |
| Aug 24, 2020 | N/A | Notice of Hearing (0) Docket Text: ELECTRONIC NOTICE of Hearing. Markman Hearing set for 12/15/2020 10:00 AM in Courtroom 17 before Judge Allison D. Burroughs. (Folan, Karen) |
| Aug 21, 2020 | 60 | Stipulation (8) Docket Text: STIPULATION regarding Protocol Governing Privilege Logs (Joint) [PROPOSED] by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| Jul 15, 2020 | 57 | Order (10) Docket Text: Judge Allison D. Burroughs: ORDER entered. ALLOWING re [49] STIPULATION (Joint) Stipulated Protocol Governing Electronically Stored Information filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (McDonagh, Christina) |
| Jul 15, 2020 | 58 | Protective Order (30) Docket Text: Judge Allison D. Burroughs: ORDER entered. PROTECTIVE ORDER. (McDonagh, Christina) |
| Jun 8, 2020 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [55] Motion for Leave to Appear Pro Hac Vice Added Mark J. Stewart and Sanjay M. Jivraj. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| Jun 5, 2020 | 54 | Stipulation (30) Docket Text: STIPULATION (Joint) [PROPOSED] Stipulated Protective Order by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 28, 2020 | N/A | Electronic Endorsement (non-order) (0) Docket Text: ELECTRONIC ENDORSEMENT APPROVING [52] Stipulation filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| May 26, 2020 | 52 | Stipulation (5) Docket Text: STIPULATION (Joint) Stipulation and [Proposed] Order to Extend Deadlines by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 21, 2020 | 51 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Joshua S. Weinger on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Weinger, Joshua) |
| May 20, 2020 | 50 | Certification pursuant to Local Rule 16.1 (3) Docket Text: CERTIFICATION pursuant to Local Rule 16.1 by Eli Lilly and Company.(Martin, Andrea) |
| May 19, 2020 | 49 | Stipulation (11) Docket Text: STIPULATION (Joint) Stipulated Protocol Governing Electronically Stored Information by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 18, 2020 | 48 | Certification pursuant to Local Rule 16.1 (3) Docket Text: CERTIFICATION pursuant to Local Rule 16.1 by Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) |
| May 15, 2020 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered APPROVING [46] Joint submission filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Folan, Karen) |
| May 14, 2020 | 46 | Joint submission (8) Docket Text: JOINT SUBMISSION pursuant to Local Rule 16.1 by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Blais, Elaine) |
| Apr 13, 2020 | N/A | Order (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered. Parties to submit a joint proposed scheduling or separate proposals if they cant agree. (Folan, Karen) |
| Apr 8, 2020 | 44 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais Requesting a Rule 16 Scheduling Conference. (Blais, Elaine) |
| Apr 22, 2019 | 43 | Memorandum & ORDER (18) Docket Text: Judge Allison D. Burroughs: MEMORANDUM AND ORDER entered. The Motion to Transfer or Stay is GRANTED in part and DENIED in part. The case will not be transferred out of this district and is hereby stayed pending resolution of the nine IPRs. SO ORDERED. (McDonagh, Christina) |
| Apr 9, 2019 | 42 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Teva Pharmaceuticals Int'l GmbH and Teva Pharmaceuticals USA in response to Lily's April 8, 2019 letter to Court [Dkt No. 41]. (Blais, Elaine) |
| Apr 8, 2019 | 41 | Letter/request (non-motion) (3) Docket Text: Letter/request (non-motion) from Andrea L. Martin in response to Teva's April 5, 2019 letter to court [Dkt 40]. (Martin, Andrea) |
| Apr 5, 2019 | 40 | Letter/request (non-motion) (3) Docket Text: Letter/request (non-motion) from Teva Pharmaceuticals Int'l GmbH and Teva Pharmaceuticals USA . (Blais, Elaine) |
| Mar 4, 2019 | 38 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Elaine Herrmann Blais . (Blais, Elaine) |
| Feb 25, 2019 | N/A | Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Hearing on Motion [18] MOTION to Transfer Case Or Stay Pending Inter Partes Review to S.D. Ind.. : Motion Hearing set for 3/5/2019 04:00 PM in Courtroom 17 before Judge Allison D. Burroughs. (Folan, Karen) |
| Jan 18, 2019 | 34 | Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Andrea L. Martin re: Timing of Board decisions. (Martin, Andrea) |
| Jan 4, 2019 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [31] Motion for Leave to File Sur-reply (Unopposed) ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (McDonagh, Christina) |
| Jan 4, 2019 | 33 | Sur-Reply to Motion (9) Docket Text: SUR-REPLY to Motion re [18] MOTION to Transfer Case Or Stay Pending Inter Partes Review to S.D. Ind.. filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Kline, Douglas) |
| Dec 21, 2018 | 29 | Reply to Response to Motion (16) Docket Text: REPLY to Response to [18] MOTION to Transfer Case Or Stay Pending Inter Partes Review to S.D. Ind.. [Leave to File Granted 12/13/18] filed by Eli Lilly and Company. (Martin, Andrea) |
| Dec 13, 2018 | N/A | Order on Motion for Leave to File (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [27] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Folan, Karen) |
| Dec 12, 2018 | 27 | Motion for Leave to File (3) Docket Text: MOTION for Leave to File Reply in support of Motion to Transfer/Stay (Dkt 18) by Eli Lilly and Company.(Martin, Andrea) |
| Dec 4, 2018 | 25 | Answer to Counterclaim (30) Docket Text: ANSWER to Counterclaim by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Kline, Douglas) |
| Nov 21, 2018 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [23] Motion for Leave to Appear Pro Hac Vice Added I. Neel Chatterjee and Natasha E. Daughtrey. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| Nov 13, 2018 | 21 | Motion for Extension of Time (3) Docket Text: MOTION for Extension of Time to December 4, 2018 to Respond to Defendant's Counterclaims and Motion to Transfer/Stay by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc..(Kline, Douglas) |
| Nov 13, 2018 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [21] Motion for Extension of Time to 12/4/18 to respond to counterclaims and motion to transfer/stay. (Folan, Karen) |
| Nov 2, 2018 | 18 | Motion to Transfer Case (3) Docket Text: MOTION to Transfer Case Or Stay Pending Inter Partes Review to S.D. Ind.. by Eli Lilly and Company.(Martin, Andrea) |
| Nov 2, 2018 | 19 | Memorandum in Support of Motion (27) Docket Text: MEMORANDUM in Support re [18] MOTION to Transfer Case Or Stay Pending Inter Partes Review to S.D. Ind.. filed by Eli Lilly and Company. (Martin, Andrea) |
| Nov 1, 2018 | 16 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Alexandra Lu on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Lu, Alexandra) |
| Oct 31, 2018 | 13 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Robert Frederickson, III on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Frederickson, Robert) |
| Oct 31, 2018 | 14 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Eric T. Romeo on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Romeo, Eric) |
| Oct 31, 2018 | 15 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Martin C. Topol on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Topol, Martin) |
| Oct 15, 2018 | N/A | Order on Motion for Extension of Time (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [11] Motion for Extension of Time to 11/2/18 to respond to complaint. (Folan, Karen) |
| Oct 12, 2018 | 11 | Motion for Extension of Time (2) Docket Text: MOTION for Extension of Time to November 2, 2018 to Respond to Complaint [Unopposed] by Eli Lilly and Company.(Martin, Andrea) |
| Oct 1, 2018 | N/A | Order on Motion for Leave to Appear (0) Docket Text: Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting [9] Motion for Leave to Appear Pro Hac Vice Added Charles E. Lipsey, William B. Raich, Danielle A. Duszczyszyn and Emily A. Gabranski. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. Pursuant to Local Rule 83.5.3, local counsel shall also file an appearance in this matter. Further, local counsel shall review all filings and shall personally appear in Court for any hearings or conferences, unless expressly excused by the Court for good cause. (McDonagh, Christina) |
| Sep 28, 2018 | N/A | Notice of Case Assignment (0) Docket Text: ELECTRONIC NOTICE of Case Assignment. Judge Allison D. Burroughs assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Marianne B. Bowler. (Finn, Mary) |
| Sep 28, 2018 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Eli Lilly and Company. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (Manolakis, Ashley) |
| Sep 28, 2018 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Andrea L. Martin on behalf of Eli Lilly and Company (Martin, Andrea) |
| Sep 28, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed Eli Lilly and Company served on 9/28/2018, answer due 10/19/2018. (Kline, Douglas) |
| Sep 27, 2018 | 1 | Complaint* (1) |
| Sep 27, 2018 | 2 | Report on the filing/termination of patent/trademark case (2) Docket Text: REPORT ON THE FILING/TERMINATION OF AN ACTION REGARDING PATENT OR TRADEMARK. (Kline, Douglas) |
| Sep 27, 2018 | 3 | Corporate Disclosure Statement (2) Docket Text: CORPORATE DISCLOSURE STATEMENT by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc... (Kline, Douglas) |
| Sep 27, 2018 | 4 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Elaine Herrmann Blais on behalf of Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. (Blais, Elaine) |
